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ABSTRACT 
Due to their cholesterol content, limiting egg intake has been widely recommended for prevention 
of cardiovascular disease (CVD). However, recent reports by the 2015 Dietary Guidelines Committee and 
AHA/ACC suggest that there is insufficient evidence that dietary cholesterol is appreciably associated 
with blood cholesterol. In addition, the literature on the association with type 2 diabetes (T2D) is 
inconsistent. These analyses aim to determine the association between egg intake and the risk of CVD and 
T2D in the Nurses’ Health Study (NHS), the Nurses’ Health II Study (NHSII), Health Professionals 
Follow-up Study (HPFS) and the NIH-AARP Diet and Health Study (AARP), and conduct a meta-
analyses.  
Egg intake was assessed via validated semi-quantitative food frequency questionnaires. Cox 
proportional hazard models, adjusted for age, lifestyle and dietary factors, were used to estimate relative 
risks (HR) and 95% Confidence Intervals (CI). We observed 12,832 and 16,570 cases of incident CVD 
and T2D in NHS, NHSII and HPFS, and 11,268 CVD mortality cases in AARP. An increase of one egg 
per day was not associated with risk of CVD in NHS, NHSII and HPFS (HR: 1.04, 95% CI: (0.96, 1.13)). 
In the AARP study an increase of one egg per day was associated with an increased risk of CVD 
mortality (HR: 1.13, 95% CI: (1.05, 1.20)) and, an increased risk of CVD mortality among diabetics (HR: 
1.25, 95%CI: (1.11, 1.41)). One egg per day was associated with an increased risk of CVD (HR: 1.05, 
95% CI: (1.01, 1.09)) in a meta-analysis of the current results and previously published studies. We also 
saw an increased risk of CVD among diabetics (HR: 1.24, 95% CI: (1.12, 1.37)).  We observed an 
increased risk of T2D with an increase of one egg per day (HR: 1.09, 95% CI: (1.01, 1.18)) in NHS, 
NHSII and HPFS, and in the meta-analysis (HR: 1.13, 95% CI: (1.07, 1.19)).  
Although there does not seem to be a significant association between egg intake and risk of CVD 
or T2D in healthy individuals, people at risk for CVD or T2D and those who currently have T2D may 
want to limit egg intake.  
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INTRODUCTION 
Obesity and related chronic diseases continue to be a problem on the global scale. Specifically, 
Cardiovascular Disease (CVD) and Type 2 Diabetes (T2D) are two diseases that cause substantial burden 
worldwide. There are many modifiable lifestyle factors that play a role in the development of both CVD 
and T2D, including overweight and obesity, physical activity, smoking status, alcohol consumption and 
diet
1, 2
. In the past, limiting dietary cholesterol intake to 300mg/day was widely recommended for 
prevention of CVD
1
. More recently, the 2015 Dietary Guidelines Advisory Report did not carry forward 
the upper limit for dietary cholesterol due to limited evidence to support that dietary cholesterol has an 
appreciable relationship with blood cholesterol levels
3
. Eggs are a major source of dietary cholesterol and 
contain about 200mg, but they also contain a variety of other nutrients beneficial to health such as 
unsaturated fats, amino acids, and B-vitamins
4
. Previous research has found that consumption of fats such 
as polyunsaturated fatty acids may reduce risk of both CVD and T2D, while consumption of saturated and 
trans fats may increase risk
5, 6
. Although a number of studies have been conducted to examine the 
relationship between egg intake and the risk of CVD and T2D, the debate remains unresolved. The 
current research focuses on the association between whole egg intake and the risk of T2D and CVD.  
In chapter 1, I examine the association between whole egg consumption and the risk of CVD in 
three prospective cohorts, the Nurses’ Health Study (NHS), Nurses’ Health Study II (NHSII) and Health 
Professionals Follow-up Study (HPFS). Although several prospective cohorts have not found any 
association between egg intake and the risk of CVD, other study designs such as cross-sectional analyses 
have found conflicting results, sparking debate in the literature
4, 7-14
. In the current analyses I assess egg 
intake of one or more eggs per day and the risk of overall CVD and of stroke and coronary heart disease 
(CHD) separately. I also examine the differences in the effect of eggs on CVD stratified by several CVD 
risk factors.  
In chapter 2, I assess the association between whole egg consumption and the risk of CVD 
mortality in the NIH-AARP Diet and Health Study (AARP). Previous publications of CVD mortality 
have found similar results to those reporting incident CVD
9, 12, 13
. No previous studies have been able to 
%∀
examine this relationship in an older population at higher risk for CVD. In the current analyses I examine 
the relationship between egg intake and the risk of CVD mortality as well as the overall association of one 
egg per day with the risk of total CVD through meta-analysis of currently published prospective cohorts.  
In chapter 3, I examine the association of whole egg consumption with the risk of T2D in the 
NHS, NHSII and HPFS cohorts. Less is known about the association between eggs and risk of T2D. 
While several studies have found an increased risk of CVD among participants with T2D, the literature on 
the risk of incident T2D with egg consumption is inconsistent
15-21
. It is possible that increased dietary 
cholesterol may lead to inflammation processes and beta-cell dysfunction that put patients at higher risk 
for development of T2D
22, 23
. In the current analyses I assess the association of egg consumption of one 
egg or more per day with the risk of incident T2D. I also combine previous reports on the subject to 
determine an overall risk of T2D with an increase of one egg per day using meta-analysis. 
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ABSTRACT 
Background 
Because eggs contain high amounts of dietary cholesterol, limiting their consumption has been 
widely recommended for prevention of cardiovascular disease (CVD). We prospectively evaluated the 
association between egg intake and CVD risk in three large cohorts.  
Methods and Results 
The study population includes women from the Nurses’ Health Study (1980-2010; N=69,387), 
Nurses’ Health Study II (1991-2011; N=90,750), and men from the Health Professionals Follow-up Study 
(1986-2010; N=43,203); all were free of diagnosed CVD, type 2 diabetes (T2D), and cancer at baseline. 
Egg intake was assessed every 4 years via validated food frequency questionnaires. Incident coronary 
heart disease (CHD) (nonfatal myocardial infarction (MI) and fatal CHD) and stroke cases were 
ascertained via medical record reviews. Relative risks (HR) and 95% confidence intervals (CI) were 
estimated using multivariate Cox proportional hazards models, adjusted for age, lifestyle and dietary 
factors. We identified 12,832 incident cases of CVD. Overall, egg consumption up to 1 egg/day was not 
significantly associated with risk of incident total CVD after multivariate adjustment (HR (CI) by 
category: <1/month: 1(ref); 1-3/month: 1.02 (0.95, 1.09); 1/week: 1.01 (0.94, 1.08); 2-4/week: 0.97 (0.91, 
1.04); 5-6/week: 1.05 (0.93, 1.18); 1+/day: 1.10(0.98, 1.23)) (p-trend=0.33). Egg intake was not 
associated with either CHD or stroke individually (p-trend: CHD=0.41, stroke=0.48). We estimated that 
replacing one egg with one serving of red and processed meats per day was associated with a 9% 
increased risk of CVD, while replacing eggs with low-fat dairy, nuts, legumes or whole grains was 
associated with a 9-11% lower risk of CVD. 
Conclusions 
Egg intake was not associated with increased risk of total CVD, stroke or CHD in these three 
prospective cohorts. However, replacing eggs with low-fat dairy, whole grains, legumes and nuts was 
associated lower CVD risk, while replacing eggs with red and processed meats was associated with 
increased risk.   
)∀
INTRODUCTION 
In the US, cardiovascular disease (CVD) is the leading cause of death in both men and women 
24
. 
Many modifiable lifestyle factors play a role in the development of CVD, including overweight and 
obesity, physical activity, smoking status, alcohol consumption and diet
 1
. In the past, limiting dietary 
cholesterol intake to 300mg/day has been widely recommended for prevention of CVD 
1
. However, due 
to the lack of effect of dietary cholesterol on blood cholesterol, the 2015 Dietary Guidelines Advisory 
Committee Report did not carry forward the upper limit for dietary cholesterol 
3
. Eggs are a major source 
of dietary cholesterol, and one egg contains about 200mg. A meta-analysis of feeding studies found that 
ingestion of dietary cholesterol had only modest effects on LDL and HDL cholesterol and little influence 
on the ratio of LDL to HDL
25
. Other research on dietary cholesterol and changes in CVD risk factors 
suggests that dietary cholesterol may increase LDL particle size, the number of large HDL particles, 
activity of Lecithin-cholesterol acyltransferase and Cholesteryl ester transfer protein and enhance reverse 
cholesterol transport, but does not change the ratio of LDL to HDL particles
 26
. In addition, although eggs 
do contain a significant amount of dietary cholesterol, other beneficial nutrients such as unsaturated fats 
and B-vitamins are also present, potentially offsetting any possible increased risk due to the cholesterol 
content 
4
. 
Multiple publications over the past decade have fueled the debate of the association between egg 
intake and the risk of CVD. Although a cross-sectional study found an increase in carotid plaque area 
with increases in egg consumption
7
, several prospective cohort studies of egg consumption have not 
found an association between egg intake and risk of coronary heart disease (CHD) 
4, 8-13
 or stroke 
9-14
 after 
adjusting for dietary and lifestyle factors. A recent meta-analysis found no association between egg intake 
up to one egg per day for either myocardial infarction (MI) or total stroke, but did find a significantly 
decreased risk of hemorrhagic stroke in those who consumed 1 or more eggs per day (HR: 0.75, 95% CI: 
(0.57, 0.99))
27
. 
The current study is an updated analyses of previous results published in JAMA in 1999
4
. In the 
previous publication, we identified 1,124 cases of CVD after 8 years of follow-up in HPFS and 14 years 
∗∀
of follow-up in NHS. The current analysis expands on the previous publication by including additional 
years of follow-up, more than ten times the number of cases and extends the analysis to the younger 
cohort of the Nurses’ Health Study II.  Specifically, in the current analyses, we have identified 12,827 
cases of CVD after 24 years of follow-up in HPFS, 30 years in NHS and 20 years in NHSII. We also 
estimated the effects of substituting other foods (red and processed meats, low-fat dairy, nuts, and whole 
grains) for eggs on risk of CVD. 
 
METHODS 
NHS, NHSII and HPFS are prospective cohort studies conducted in the US that began in 1976, 
1989 and 1986, respectively. NHS includes 121,701 female registered nurses between the ages of 30-55.  
NHSII includes 116,430 female registered nurses between the ages of 25-44. HPFS includes 51,529 male 
health professionals between the ages of 40-75. Participants in all three cohorts completed validated 
questionnaires with information on disease diagnosis, disease risk factors and lifestyle characteristics 
every two years. Dietary information was collected every four years and follow-up rates were over 90%
28-
30
. For all cohorts, participants were excluded if they reported unrealistic intake on the FFQ (>70 items 
blank, <500 or >3500 kcals/day for women and <800 or >4200 kcals/day for men), or if they had been 
previously diagnosed with cancer, T2D or CVD. In addition, participants were excluded if egg intake or 
total calories were missing at baseline. The final sample included 69,387 participants in NHS, 90,750 
participants in NHSII and 43,159 participants in HPFS. The study protocol was approved by the 
Institutional Review Board at the Brigham and Women’s Hospital in Boston.  
 
Assessment of Egg Intake 
Egg intake was reported every four years beginning in 1980, 1991 and 1986 for NHS, NHSII and 
HPFS, using a validated semi-quantitative FFQ with 61 items in 1980 and 131 items in subsequent 
questionnaires
31
. Participants were asked how often on average they have consumed eggs in the past year. 
Reported intake includes whole eggs prepared separately from other foods. FFQs were validated against 
+∀
four 7-day weighed diet records in 173 women. Correlation between the FFQ and weighed food records 
was good, with Pearson correlation coefficients, corrected for within-person variation, for specific food 
items on the FFQ ranging from 0.17 (spinach) to 0.94 (yogurt and beer)
32
. Specifically, the de-attenuated 
correlation between the FFQ and weighed food record for egg intake was 0.77
32
. A similar validation 
study was conducted in 127 men in HPFS (de-attenuated correlation coefficient =0.80)
33
. Egg intake was 
analyzed in 6 categories of intake as follows: 0-1 per month, 2-3 per month, 1 per week, 2-4 per week, 5-6 
per week and ≥1 per day for primary analyses. An additional category of ≥2 per day was used in 
secondary analyses.  
 
Assessment of Incident CVD 
Incident non-fatal CVD was initially ascertained through self-report questionnaire every two 
years. Fatal outcomes were ascertained by reports from the family and systematic searches of the National 
Death Index. Physicians blinded to risk factor status of the participants confirmed diagnoses through 
medical record review. CVD includes diagnoses of nonfatal MI, fatal CHD and stroke. The World Health 
Organization criteria were used to diagnose MI 
34
. The patient must have typical symptoms and elevated 
cardiac enzymes or electrocardiographic changes.  Stroke was confirmed using criteria from the National 
Survey of Stroke which required a typical neurologic defect of rapid onset
35
. Stroke subtypes (ischemic 
and hemorrhagic) were determined by through medical record review by a neurologist using the Perth 
Community Stroke Study Criteria
36
. Ischemic stroke included thrombotic, embolic or unspecified non-
hemorrhagic, while hemorrhagic stroke included subarachnoid and intraparenchymal hemorrhages. When 
medical records were not available but confirmation was provided through interview or letter, cases were 
considered probable. Analyses include both confirmed and probable cases of CVD. Analyses including 
only confirmed cases produced virtually identical results. Date of death was collected through review of 
medical records, the National Death Index, tumor registries and death certificates. 
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Statistical Methods 
Follow-up began with the return of the first dietary questionnaire, in 1980, 1991 and 1986 for the 
NHSI, NHSII and HPFS cohorts, respectively. Person-time was included until diagnosis of CVD, death or 
the end of follow-up on June 30
th
, 2010 for NHS, June 30
th
 2011 for NHSII and January 31
st
, 2010 for 
HPFS. Hazard ratios and 95% confidence intervals were calculated using multivariate adjusted Cox 
proportional hazards analyses for incident CVD. We used a cumulative average update of dietary 
variables, including egg intake, to limit within-person variation and to represent long-term diet
37
. The 
proportional hazards assumption was tested through a likelihood ratio test of models with and without an 
egg intake and time-to event interaction term. A possible linear trend for the RR estimates across 
categories of egg consumption was evaluated using the median of each category of egg intake as the dose 
of egg consumption 
38
. Total CVD was analyzed separately as total CHD (including non-fatal MI and 
fatal CHD) and total stroke. 
Model 1 included adjustment for age, cohort, and two year time intervals. Model 2 was 
additionally adjusted for sex, race/ethnicity, BMI, smoking status, physical activity, family history of MI, 
baseline diagnosis with hypertension or high blood cholesterol, previous statin use, alcohol consumption, 
multivitamin use and for women; postmenopausal status, use of menopausal hormones, and use of oral 
contraceptives. Model 3 additionally included total energy intake and foods associated with egg intake 
(e.g. red meat, bacon, other processed meat, whole milk, refined carbohydrates, potatoes and French fries, 
juice, sugar-sweetened beverages and coffee). Adherence to the western dietary pattern was also 
considered as a possible confounder but not included in the final model because it did not significantly 
change hazard ratios or overall model fit. Stratified analyses and likelihood ratio tests for interactions 
were conducted for updated BMI, physical activity, self-reported hypertension (including use of anti-
hypertensive medication), self-reported high blood cholesterol (including use of cholesterol lowering 
medication), family history of MI, statin use, smoking status, age and self-reported T2D. Stratified 
analysis of T2D includes participants reporting T2D at baseline.  
∃−∀
In sensitivity analyses, the results for total stroke were further examined by ischemic and 
hemorrhagic stroke. We also examined results for coronary artery bypass graft (CABG). We examined 
the risk of CVD for egg intake of 2 or more eggs per day. In addition, we explored the risk of CVD for 
total egg intake (including eggs in baked goods). To determine whether a cumulative average update was 
the appropriate model for risk of CVD, we examined results from baseline diet only, which would be used 
with a long latency disease but does not minimize measurement error in dietary variables. We also 
examined results from a model using the most recent diet which would be useful for a shorter latency 
disease
37
. To account for the possibility that diagnosis with an intermediate endpoint of CVD could 
introduce confounding, we examined results where we stopped updating diet after diagnosis with T2D, 
hypertension, high blood cholesterol, angina, CABG or beginning statin use
39
. We examined the effects of 
substituting eggs for 1 serving of other common food groups on risk of total CVD by including 
continuous variables for both eggs and the other food in the model along with other non-dietary 
confounders. We then used the differences between the beta-coefficients, variance and the covariance of 
eggs and the other food to calculate HR’s and 95% CI’s
40
. All p-values are two-sided and statistical 
analyses were performed using SAS v.9.3 (SAS Institute, Inc., Cary, NC). 
 
RESULTS 
Through the end of follow-up, we identified 12,832 total cases of CVD (NHS: 5,698; NHSII: 
998; HPFS: 6,145) including 4,805 cases of total stroke, 750 cases of hemorrhagic stroke, 2,533 cases of 
ischemic stroke, and 8,127 cases of CHD. In 1994 for NHS and HPFS, and 1995 for NHSII, higher egg 
intake was associated with higher prevalence of T2D, a higher intake of total calories, red meat, bacon, 
other processed meat, refined carbohydrates, potatoes, whole milk and coffee (Table 1). Higher egg intake 
was inversely associated with self-reported high blood cholesterol levels and statin use.  
In analyses adjusted only for age and cohort, intake one or more egg per day was associated with 
a higher risk of CVD compared to intake of less than one egg per month (HR: 1.25, 95% CI: (1.12, 1.39)) 
(Table 2). After further adjustment for lifestyle and dietary characteristics associated with egg intake, the 
∃∃∀
association was attenuated and no longer statistically significant (HR: 1.10, 95% CI: (0.98, 1.23)). Similar 
patterns were seen in all three cohorts individually. There was no significant association between higher 
egg intake and risk of total CHD (p-trend=0.41) or total stroke (p-trend=0.48) when examined separately 
(Table 3). There was no significant interaction between egg intake and age, BMI, physical activity, 
smoking, high blood cholesterol or family history of MI (Table 4). We found borderline significant 
interactions for hypertension (p=0.05), and T2D (p=0.05). Participants who reported hypertension had a 
significantly increased risk of CVD with egg consumption of 1 egg or more per day (HR: 1.27, 95% CI: 
(1.09, 1.47)) while participants without hypertension did not (HR: 0.89, 95% CI: (0.74, 1.06)). 
Participants with T2D had a higher risk of CVD with consumption of one egg or more per day (HR: 1.23, 
95% CI: (0.93, 1.62)) than participants without T2D (HR: 1.03, 95% CI: (0.91, 1.17)). These trends were 
evident in all three cohorts when examined individually. When we modeled the substitution of one egg 
for one serving of another food, we saw an increased risk of CVD when eggs were replaced by red and 
processed meat (HR: 1.09, 95% CI: (1.02, 1.17)), and a decreased risk of CVD when eggs were replaced 
by low-fat dairy (HR: 0.91, 95% CI: (0.86, 0.96)), whole grains (HR: 0.89, 95% CI: (0.83, 0.94)), 
legumes (HR: 0.91, 95% CI: (0.84, 0.99)) and nuts (HR: 0.89, 95% CI: (0.83, 0.95)) (Figure 1). 
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Table 1. Age-Standardized Characteristics of Participants in NHSI, NHSII and HPFS in 1994 
Abbreviations: Number (No), Year (y), week (wk), servings (serv), ounces (oz), grams (g), sugar-sweetened beverages (SSB) 
*
Body mass index calculated as weight in kilograms divided by height in meters squared 
†
Includes prevalent cases before baseline
 
and incident cases until the return of the 1994 questionnaire (1995 in NHSII) 
‡
Includes incident cases until the return of the 1994 questionnaire (1995 in NHSII) 
 Whole Egg Intake 
 Nurses’ Health Study I  Nurses’ Health Study II  Health Professionals Follow-Up 
Study 
Characteristics 0/month 2-4/week ≥1/day  0/month 2-4/week ≥1/day  0/month 2-4/week ≥1/day 
Participants, No 4,159 16,058 1,359  16,634 11,954 371  6,810 8,948 1,385 
Age, mean, y 61.0 59.8 59.8  40.3 40.5 41.1  60.3 61.8 62.1 
Body Mass Index
*
, mean, kg/m
2
 25.5 27.0 27.5  24.9 26.6 27.4  25.4 26.4 26.2 
Physical Activity, mean, Met h/wk 20.2 19.2 19.3  26.6 18.9 22.0  38.3 34.2 35.0 
White race, % 98 98 98  96 96 94  95 95 95 
Smoking Status            
   Never smoker, % 40 48 43  65 67 67  54 47 42 
   Past smoker, % 43 40 42  25 22 20  42 43 44 
   Current smoker, % 17 12 15  10 11 13  4 10 14 
Postmenopausal, % 90 89 89  8 7 7     
Current menopausal hormone use, % 35 37 37  6 5 4     
Current oral contraceptive use, %     9 7 8     
Family history of diabetes mellitus, % 29 30 32  16 17 19  15 14 13 
Family history of myocardial infarction, % 20 18 20  13 12 10  37 29 27 
High blood pressure
†
, % 40 40 44  9 10 13  35 34 28 
High blood cholesterol
†
, % 50 45 45  20 16 14  48 32 28 
Type 2 diabetes
‡
, % 4 6 8  0 1 1  4 6 9 
Current multivitamin use, % 42 46 48  59 60 63  64 59 59 
Current statin use, % 23 17 16  4 2 2  13 3 3 
Dietary intake, mean            
   Total Energy, kcal/d 1,459 1,787 1,882  1,583 2,088 2,202  1,791 2,160 2,348 
   Alcohol, g/d 5.8 6.4 6.5  3.1 3.5 3.1  9.3 12.3 11.5 
   Bacon, servings/d 0.0 0.1 0.2  0.0 0.1 0.2  0.0 0.2 0.3 
   Red meat, servings/d 0.9 1.0 1.1  0.5 0.9 0.9  0.5 0.9 1.1 
   Other processed meat, servings/d 0.2 0.2 0.3  0.1 0.2 0.3  0.1 0.3 0.3 
   Refined carbohydrates, servings/d 1.0 1.3 1.2  0.8 1.2 1.4  0.8 1.1 1.3 
   Potatoes, servings/d 0.7 0.8 0.8  0.4 0.6 0.6  0.5 0.6 0.7 
   Whole milk, servings/d 0.1 0.2 0.3  0.0 0.1 0.2  0.0 0.2 0.3 
   Coffee, servings/d 2.2 2.4 2.4  1.5 1.6 1.6  1.6 2.1 2.3 
   Juice, servings/d 0.5 0.5 0.5  0.6 0.8 0.8  0.8 0.8 0.8 
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Table 2. Risk of Incident Cardiovascular Disease According to Categories of Whole Egg Consumption in NHSI, NHSII and HPFS 
 Frequency of Consumption Categories 
p-value 
for 
trend
‡ 
HR (95% CI) 
for a 1 serving 
per day 
increase 
 <1/month 1-3/month 1/week 2-4/week 5-6/week ≥1/day 
Nurses’ Health I Study 
Cases/ Person years, No. 346/106,090 845/249,856 2,748/843,273 1,446/586115 143/60,602 161/62,978  
 
Age adjusted model 1 1 1.10 (0.97, 1.25) 1.03 (0.92, 1.15) 1.03 (0.91, 1.15) 1.16 (0.95, 1.41) 1.25 (1.03, 1.50) 0.13 1.10 (0.97, 1.25) 
Multivariable model 2
*
 1 1.15 (1.01, 1.30) 1.11 (0.99, 1.24) 1.09 (0.97, 1.23) 1.22 (1.00, 1.49) 1.24 (1.02, 1.49) 0.12 1.10 (0.97, 1.25) 
Multivariable model 3
†
 1 1.13 (1.00, 1.28) 1.08 (0.96, 1.21) 1.05 (0.93, 1.19) 1.16 (0.95, 1.41) 1.19 (0.98, 1.45) 0.36 1.06 (0.93, 1.22) 
         
Nurses’ Health II Study 
Cases/ Person years, No. 167/333,857 312/659,254 394/678,556 111/274,443 10/18,036 4/10,557  
 
Age adjusted model 1 1 1.00 (0.83, 1.20) 1.12 (0.94, 1.35) 0.98 (0.77, 1.24) 1.23 (0.65, 2.34) 0.77 (0.29, 2.09) 0.78 1.06 (0.70, 1.60) 
Multivariable model 2
*
 1 0.99 (0.82, 1.19) 1.10 (0.91, 1.32) 0.91 (0.72, 1.17) 1.10 (0.58, 2.10) 0.72 (0.26, 1.93) 0.70 0.92 (0.61, 1.40) 
Multivariable model 3
†
 1 0.93 (0.77, 1.13) 1.01 (0.83, 1.23) 0.82 (0.63, 1.07) 0.97 (0.50, 1.86) 0.60 (0.22, 1.65) 0.25 0.77 (0.48, 1.21) 
         
Health Professionals Follow-up Study 
Cases/ Person years, No. 840/139,344 1,205/203,922 2,059/308,344 1,540/238,339 212/30,784 289/38,753  
 
Age adjusted model 1 1 1.02 (0.94, 1.12) 1.05 (0.97, 1.14) 1.09 (1.00, 1.19) 1.19 (1.02, 1.39) 1.26 (1.10, 1.44) <0.001 1.19 (1.09, 1.30) 
Multivariable model 2
*
 1 1.01 (0.92, 1.10) 1.04 (0.96, 1.13) 1.05 (0.96, 1.15) 1.13 (0.97, 1.32) 1.20 (1.04, 1.37) 0.003 1.15 (1.05, 1.25) 
Multivariable model 3
†
 1 0.98 (0.89, 1.07) 0.98 (0.90, 1.07) 0.97 (0.88, 1.07) 1.03 (0.88, 1.22) 1.09 (0.94, 1.27) 0.16 1.07 (0.97, 1.18) 
         
Pooled Results 
Cases/ Person years, No. 1,353/579,281 2,362/1,113,032 5,201/1,830,173 3,097/1,098,897 365/109,422 454/112,288  
 
4Age adjusted model 1 1 1.05 (0.98, 1.12) 1.05 (0.98, 1.11) 1.06 (0.99, 1.13) 1.18 (1.05, 1.33) 1.25 (1.12, 1.39) <0.001 1.16 (1.08, 1.25) 
Multivariable model 2
* 
1 1.05 (0.98, 1.12) 1.06 (1.00, 1.13) 1.05 (0.98, 1.12) 1.15 (1.02, 1.29) 1.19 (1.07, 1.33) 0.003 1.12 (1.04, 1.20) 
Multivariable model 3
† 
1 1.02 (0.95, 1.09) 1.01 (0.94, 1.07) 0.97 (0.91, 1.04) 1.05 (0.93, 1.18) 1.10 (0.98, 1.23) 0.33 1.04 (0.96, 1.13) 
*
Multivariable model 2 includes: age (months), sex (male, female), smoking status (never, former, current), BMI (kg/m
2
: categorical <23, 23-<25, 25-<27, 27-
<30, 30-<35, 35-<40, 40+), physical activity (MET-hours/week: categorical <3, 3-<9, 9-<18, 18-<27, 27+), oral contraceptive use (never, former, current), post-
menopausal hormone use (premenopausal, never, former, current), race (Caucasian, other), family history of MI (yes, no), baseline high blood cholesterol (yes, 
no), baseline high blood pressure (yes, no) statin use (yes, no), Alcohol intake (servings/d), multivitamin use (yes, no) 
†
Multivariable model 3 includes: 
 
model 2 with total calories (per day: quintiles), whole milk (categorical: servings/d), bacon (categorical: servings/d), red meat 
(categorical: servings/d), other processed meats (categorical: servings/d), refined carbohydrates (categorical: servings/d), potatoes (categorical: servings/d), 
coffee (categorical: servings/d), juice (categorical: servings/d), and sugar-sweetened beverages (categorical: servings/d) 
‡
P-values for trend based on continuous egg variable  
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Table 3. Risk of Incident Cardiovascular Disease Types According to Categories of Whole Egg Consumption in NHSI, NHSII and HPFS
*
 
* 
All results use multivariable model 3 and are adjusted for: age (months), sex (male, female), smoking status (never, former, current), BMI (kg/m
2
: categorical 
<23, 23-<25, 25-<27, 27-<30, 30-<35, 35-<40, 40+), physical activity (MET-hours/week: categorical <3, 3-<9, 9-<18, 18-<27, 27+), oral contraceptive use 
(never, former, current), post-menopausal hormone use (premenopausal, never, former, current), race (Caucasian, other), family history of MI (yes, no), baseline 
high blood cholesterol (yes, no), baseline high blood pressure (yes, no) statin use (yes, no), Alcohol intake (servings/d), multivitamin use (yes, no), total calories 
(per day: quintiles), whole milk (categorical: servings/d), bacon (categorical: servings/d), red meat (categorical: servings/d), other processed meat (categorical: 
servings/d), refined carbohydrates (categorical: servings/d), potatoes (categorical: servings/d), coffee (categorical: servings/d), juice (categorical: servings/d), and 
sugar-sweetened beverages (categorical: servings/d) 
†
P-values for trend based on continuous egg variable derived from the median egg intake in each category of consumption 
 
 
  Frequency of Consumption Categories p-
value 
for 
trend
† 
HR (95% CI) 
for a 1 
serving per 
day increase 
Cohort 
 <1/month 1-3/month 1/week 2-4/week 5-6/week ≥1/day 
 Total CHD (non-fatal MI and fatal CHD)
 
  
NHSI Cases/ Person years, No. 193/106,201 438/250,164 1,448/844,264 816/586,615 79/60,648 86/63,047   
 HR (95% CI) 1 1.06 (0.90, 1.26) 1.05 (0.90, 1.22) 1.04 (0.88, 1.22) 1.11 (0.84, 1.45) 1.08 (0.83, 1.41) 0.67 1.04 (0.87, 
1.25) 
NHSII Cases/ Person years, No. 86/333,931 163/659,392 201/678,745 49/274,490 8/18,038 2/10,558   
 HR (95% CI) 1 0.90 (0.69, 1.18) 0.92 (0.70, 1.20) 0.63 (0.43, 0.92) 1.24 (0.58, 2.64) 0.52 (0.13, 2.17) 0.12 0.59 (0.30, 
1.14) 
HPFS Cases/ Person years, No. 609/139,528 891/204,179 1,523/308,756 1,157/238,657 157/30,820 221/38,814   
 HR (95% CI) 1 0.98 (0.88, 1.09) 1.00 (0.90, 1.11) 1.00 (0.89, 1.12) 1.03 (0.85, 1.24) 1.12 (0.95, 1.33) 0.14 1.04 (0.96, 
1.14) 
Pooled Cases/ Person years, No. 888/579,660 1,492/1,113,735 3,172/1,831,765 2,022/1,099,762 244/109,506 309/112,419   
 HR (95% CI) 1 1.00 (0.92, 1.09) 1.00 (0.92, 1.08) 0.98 (0.89, 1.06) 1.03 (0.88, 1.19) 1.08 (0.93, 1.24) 0.41 1.04 (0.94, 
1.15) 
    
 Total Stroke
 
  
NHSI Cases/ Person years, No. 156/106,205 419/250,121 1,333/844,186 641/586,629 64/60,648 78/63,034   
 HR (95% CI) 1 1.23 (1.02, 1.48) 1.14 (0.96, 1.35) 1.07 (0.89, 1.28) 1.20 (0.89, 1.62) 1.36 (1.03, 1.81) 0.38 1.09 (0.90, 
1.33) 
NHSII Cases/ Person years, No. 82/333,938 150/659,397 194/678,720 64/274,484 2/18,041 2/10,557   
 HR (95% CI) 1 0.96 (0.72, 1.26) 1.11 (0.84, 1.46) 1.09 (0.76, 1.56) 0.47 (0.12, 1.95) 0.69 (0.17, 2.88) 0.93 1.03 (0.55, 
1.93) 
HPFS Cases/ Person years, No. 234/139,692 318/204,432 547/309,131 391/238,925 57/30,869 73/38,845   
 HR (95% CI) 1 0.96 (0.80, 1.15) 0.93 (0.79, 1.11) 0.91 (0.76, 1.10) 1.08 (0.79, 1.48) 1.08 (0.81, 1.44) 0.51 1.07 (0.89, 
1.30) 
Pooled Cases/ Person years, No. 472/579,835 887/1,113,950 2,074/1,832,037 1,096/1,100,038 123/109,558 153/112,436   
 HR (95% CI) 1 1.06 (0.94, 1.18) 1.03 (0.92, 1.14) 0.97 (0.86, 1.09) 1.08 (0.88, 1.33) 1.17 (0.96, 1.42) 0.48 1.05 (0.92, 
1.20) 
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Table 4. Stratified Analysis of Risk of Incident Cardiovascular Disease According to Categories of Whole Egg Consumption in NHSI, NHSII and 
HPFS: Pooled Results
*
 
Variable 
Cases/Person 
years, No. 
Frequency of Consumption Categories p-value 
for trend
†
 <1/month 1-3/month 1/week 2-4/week 5-6/week ≥1/day 
Age < 60
 
5,158/3,868,171 1 1.00 (0.90, 1.10) 0.99 (0.89, 1.09) 0.95 (0.85, 1.06) 1.01 (0.84, 1.22) 0.92 (0.77, 1.11) 0.32 
Age ≥ 60 7,674/974,932 1 1.04 (0.95, 1.14) 1.02 (0.94, 1.11) 1.00 (0.91, 1.09) 1.06 (0.90, 1.25) 1.24 (1.07, 1.43) 0.03 
   
BMI < 25 5,672/2,515,663 1 0.99 (0.89, 1.09) 1.00 (0.91, 1.09) 0.98 (0.88, 1.09) 0.95 (0.78, 1.16) 1.06 (0.89, 1.26) 0.71 
BMI ≥ 25 7,160/2,327,440 1 1.05 (0.95, 1.15) 1.01 (0.93, 1.11) 0.99 (0.89, 1.09) 1.12 (0.96, 1.32) 1.12 (0.96, 1.31) 0.29 
         
≥ 9 MET/wk  PA 5,199/2,174,760 1 0.98 (0.89, 1.09) 0.98 (0.90, 1.09) 0.97 (0.87, 1.08) 1.08 (0.89, 1.31) 1.08 (0.89, 1.31) 0.45 
< 9 MET/wk PA 7,633/2,668,343 1 1.04 (0.95, 1.14) 1.03 (0.94, 1.12) 0.98 (0.89, 1.08) 1.02 (0.87, 1.20) 1.13 (0.97, 1.31) 0.48 
   
Never smoker 5,242/2,781,653 1 1.03 (0.92, 1.14) 1.07 (0.97, 1.18) 1.03 (0.93, 1.15) 1.16 (0.95, 1.41) 1.18 (0.98, 1.42) 0.08 
Ever smoker 7,590/2,061,450 1 1.02 (0.93, 1.12) 0.96 (0.88, 1.05) 0.94 (0.85, 1.03) 1.00 (0.85, 1.18) 1.06 (0.92, 1.23) 0.89 
   
No hypertension 4,780/3,403,118 1 0.99 (0.89, 1.11) 0.97 (0.87, 1.07) 0.88 (0.78, 0.98) 0.89 (0.73, 1.07) 0.88 (0.74, 1.06) 0.03 
Hypertension 8,052/1,439,985 1 1.04 (0.95, 1.14) 1.04 (0.95, 1.13) 1.05 (0.96, 1.15) 1.19 (1.02, 1.41) 1.27 (1.09, 1.47) 0.001 
         
Normal blood cholesterol 6,039/3,232,018 1 0.99 (0.89, 1.11) 1.05 (0.95, 1.16) 1.02 (0.92, 1.14) 1.07 (0.90, 1.26) 1.13 (0.97, 1.33) 0.09 
High blood cholesterol 6,793/1,611,085 1 1.05 (0.96, 1.15) 0.97 (0.89, 1.06) 0.94 (0.85, 1.03) 1.08 (0.89, 1.31) 1.10 (0.92, 1.31) 0.95 
         
No family history 8,595/3,511,746 1 1.05 (0.96, 1.14) 1.01 (0.93, 1.10) 0.98 (0.90, 1.07) 1.03 (0.88, 1.19) 1.11 (0.97, 1.28) 0.55 
Family history of MI 4,237/1,331,357 1 0.96 (0.85, 1.07) 0.97 (0.87, 1.08) 0.94 (0.83, 1.06) 1.05 (0.84, 1.30) 1.06 (0.87, 1.30) 0.50 
         
No statin use 10,636/4,412,189 1 1.05 (0.97, 1.13) 1.03 (0.96, 1.11) 0.99 (0.92, 1.07) 1.08 (0.94, 1.22) 1.11 (0.99, 1.26) 0.30 
Statin use 2,196/430,914 1 0.92 (0.78, 1.07) 0.94 (0.81, 1.08) 0.94 (0.79, 1.12) 1.00 (0.67, 1.49) 1.08 (0.76, 1.52) 0.63 
         
No T2D diagnosis 10,951/4,667,314 1 1.02 (0.95, 1.10) 1.00 (0.93, 1.07) 0.95 (0.88, 1.02) 1.02 (0.89, 1.17) 1.03 (0.91, 1.17) 0.76 
T2D diagnosis
 
2,269/216,491 1 0.97 (0.79, 1.18) 0.96 (0.80, 1.15) 0.99 (0.82, 1.21) 1.08 (0.80, 1.46) 1.23 (0.93, 1.62) 0.05 
* 
All results use multivariable model 3 and are adjusted for: age (months), sex (male, female), smoking status (never, former, current), BMI (kg/m
2
: categorical 
<23, 23-<25, 25-<27, 27-<30, 30-<35, 35-<40, 40+), physical activity (MET-hours/week: categorical <3, 3-<9, 9-<18, 18-<27, 27+), oral contraceptive use 
(never, former, current), post-menopausal hormone use (premenopausal, never, former, current), race (Caucasian, other), family history of MI (yes, no), baseline 
high blood cholesterol (yes, no), baseline high blood pressure (yes, no) statin use (yes, no), Alcohol intake (servings/d), multivitamin use (yes, no), total calories 
(per day: quintiles), whole milk (categorical: servings/d), bacon (categorical: servings/d), red meat (categorical: servings/d), other processed meat (categorical: 
servings/d), refined carbohydrates (categorical: servings/d), potatoes (categorical: servings/d), coffee (categorical: servings/d), juice (categorical: servings/d), and 
sugar-sweetened beverages (categorical: servings/d) 
†
P-values for trend based on continuous egg variable derived from the median egg intake in each category of consumption 
‡
P-values for interaction calculated using the likelihood ratio test 
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Table 4 (Continued) 
Variable 
Cases/Person 
years, No. 
HR (95% CI) 
for a 1 serving 
per day increase 
p-int .
‡
 
Age < 60
 
5,158/3,868,171 0.94 (0.83, 1.06) 0.41 
Age ≥ 60 7,674/974,932 1.12 (1.01, 1.24)  
  
BMI < 25 5,672/2,515,663 1.02 (0.90, 1.16) 0.51 
BMI ≥ 25 7,160/2,327,440 1.06 (0.95, 1.18)  
    
≥ 9 MET/wk  PA 5,199/2,174,760 1.04 (0.94, 1.15) 0.94 
< 9 MET/wk PA 7,633/2,668,343 1.05 (0.92, 1.20)  
  
Never smoker 5,242/2,781,653 1.12 (0.98, 1.27) 0.63 
Ever smoker 7,590/2,061,450 1.01 (0.91, 1.12)  
  
No hypertension 4,780/3,403,118 0.87 (0.76, 0.99) 0.05 
Hypertension 8,052/1,439,985 1.18 (1.07, 1.31)  
    
Normal blood cholesterol 6,039/3,232,018 1.10 (0.99, 1.22) 0.18 
High blood cholesterol 6,793/1,611,085 1.00 (0.88, 1.13)  
    
No family history 8,595/3,511,746 1.03 (0.93, 1.14) 0.88 
Family history of MI 4,237/1,331,357 1.05 (0.91, 1.21)  
    
No statin use 10,636/4,412,189 1.05 (0.96, 1.14) 0.78 
Statin use 2,196/430,914 1.06 (0.83, 1.35)  
    
No T2D diagnosis 10,951/4,667,314 0.99 (0.90, 1.08) 0.05 
T2D diagnosis
 
2,269/216,491 1.21 (1.00, 1.46)  
* 
All results use multivariable model 3 and are adjusted for: age (months), sex (male, female), smoking status (never, former, current), BMI (kg/m
2
: categorical 
<23, 23-<25, 25-<27, 27-<30, 30-<35, 35-<40, 40+), physical activity (MET-hours/week: categorical <3, 3-<9, 9-<18, 18-<27, 27+), oral contraceptive use 
(never, former, current), post-menopausal hormone use (premenopausal, never, former, current), race (Caucasian, other), family history of MI (yes, no), baseline 
high blood cholesterol (yes, no), baseline high blood pressure (yes, no) statin use (yes, no), Alcohol intake (servings/d), multivitamin use (yes, no), total calories 
(per day: quintiles), whole milk (categorical: servings/d), bacon (categorical: servings/d), red meat (categorical: servings/d), other processed meat (categorical: 
servings/d), refined carbohydrates (categorical: servings/d), potatoes (categorical: servings/d), coffee (categorical: servings/d), juice (categorical: servings/d), and 
sugar-sweetened beverages (categorical: servings/d) 
†
P-values for trend based on continuous egg variable derived from the median egg intake in each category of consumption 
‡
P-values for interaction calculated using the likelihood ratio test 
!∀#
 
 
Figure 1. Hazard ratios and 95% CI’s for incident CVD associated with replacement of eggs by other food 
groups. Adjusted for: age (months), sex (male, female), smoking status (never, former, current), BMI 
(kg/m
2
: categorical <23, 23-<25, 25-<27, 27-<30, 30-<35, 35-<40, 40+), physical activity (MET-
hours/week: categorical <3, 3-<9, 9-<18, 18-<27, 27+), oral contraceptive use (never, former, current), 
post-menopausal hormone use (premenopausal, never, former, current), race (Caucasian, other), family 
history of MI (yes, no), baseline high blood cholesterol (yes, no), baseline high blood pressure (yes, no) 
statin use (yes, no), Alcohol intake (servings/d), multivitamin use (yes, no), total calories (per day: 
quintiles) 
 
Mean Egg intake at baseline was 0.42 eggs/day in NHS, 0.18 eggs/day in NHSII and 0.34 
eggs/day in HPFS. Egg intake in NHS and HPFS decreased between 1980 and 1990, then remained 
constant in later years (Figure 2).  In NHSII, mean egg intake was lower than in NHS and HPFS, but also 
remained relatively constant during follow-up. 
 
 
Figure 2. Trends in egg consumption over time. Mean egg intake calculated in NHS, NHSII and HPFS for 
each questionnaire returned. 
!∃#
 
 
In sensitivity analyses, we observed no significantly increased risk of CVD for participants 
consuming 2 or more eggs per day (HR for ≥2/day compared to <1/month: 1.04; 95% CI: 0.84, 1.30); 
however, there were only 94 cases of CVD for this category (Table 5). Results were similar when eggs 
from all sources were included (HR for ≥2/day compared to <1/month: 1.02, 95% CI: (0.85, 1.23)) (Table 
6). When the risk of total stroke was examined by ischemic (2,533 cases, p-trend=0.27) and hemorrhagic 
stroke (750 cases, p-trend=0.22), we did not see a significantly increased risk of either (Table 7). 
Similarly, we did not see an increased risk with egg intake and report of CVD including CABG (21,376 
cases, p-trend=0.93) (HR for ≥1/day: 1.03, 95% CI: (0.94, 1.13)). We also did not see any clinically 
significant changes in egg intake after diagnosis with intermediate outcomes such as T2D, hypertension, 
high blood cholesterol, statin use, CABG or angina, nor did we see any significant increases in risk of 
CVD when we stopped updating diet after diagnosis of the above intermediate outcomes (HR for ≥1/day: 
1.10, 95% CI: (0.97, 1.25)). We saw no significant differences in results when used a simple update of 
diet each year rather than a cumulative average (HR for ≥1/day: 1.09, 95% CI: (0.98, 1.23)), or when we 
used baseline diet only (HR for ≥1/day: 1.07, 95% CI: (0.98, 1.18)).  
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Table 5. Risk of Incident Cardiovascular Disease According to Seven Categories of Egg Consumption
*
 
 Frequency of Consumption Categories  p-value 
for trend
† 
Cohort <1/month 1-3/month 1/week 2-4/week 5-6/week 1/day ≥2/day 
Cases/Person-years, No. 1,353/579,291 2,362/1,113,032 5,201/1,830,169 3,097/1,098,897 365/109,422 360/91,963 94/20,325  
NHS 1 1.13 (1.00, 1.28) 1.08 (0.96, 1.21) 1.05 (0.93, 1.19) 1.16 (0.95, 1.41) 1.21 (0.99, 1.47) 1.11 (0.67, 1.81) 0.50 
NHSII 1 0.93 (0.77, 1.13) 1.01 (0.83, 1.23) 0.82 (0.63, 1.07) 0.97 (0.50, 1.86) 0.52 (0.16, 1.65) 1.17 (0.16, 8.54) 0.32 
HPFS 1 0.98 (0.89, 1.07) 0.98 (0.90, 1.07) 0.97 (0.88, 1.07) 1.03 (0.88, 1.20) 1.11 (0.94, 1.30) 1.06 (0.83, 1.36) 0.27 
Pooled Results 1 1.02 (0.95, 1.09) 1.01 (0.94, 1.07) 0.97 (0.91, 1.04) 1.05 (0.92, 1.18) 1.11 (0.98, 1.25) 1.04 (0.84, 1.30) 0.53 
* 
All results use multivariable model 3 and are adjusted for: age (months), sex (male, female), smoking status (never, former, current), BMI (kg/m
2
: categorical 
<23, 23-<25, 25-<27, 27-<30, 30-<35, 35-<40, 40+), physical activity (MET-hours/week: categorical <3, 3-<9, 9-<18, 18-<27, 27+), oral contraceptive use 
(never, former, current), post-menopausal hormone use (premenopausal, never, former, current), race (Caucasian, other), family history of MI (yes, no), baseline 
high blood cholesterol (yes, no), baseline high blood pressure (yes, no) statin use (yes, no), Alcohol intake (servings/d), multivitamin use (yes, no), total calories 
(per day: quintiles), whole milk (categorical: servings/d), bacon (categorical: servings/d), red meat (categorical: servings/d), other processed meat (categorical: 
servings/d), refined carbohydrates (categorical: servings/d), potatoes (categorical: servings/d), coffee (categorical: servings/d), juice (categorical: servings/d), and 
sugar-sweetened beverages (categorical: servings/d) 
†
P-values for trend based on continuous egg variable derived from the median egg intake in each category of consumption 
 
 
Table 6. Risk of Incident Cardiovascular Disease According to Categories of Total Egg Consumption, Including Eggs in Mixed Foods
* 
 Frequency of Consumption Categories  p-value 
for trend
† 
Cohort <1/month 1-3/month 1/week 2-4/week 5-6/week 1/day ≥2/day 
Cases/Person-years, No. 752/319,578 1,920/899,932 5,407/2,113,589 3,525/1,225,671 545/141,509 537/116,139 146/26,506  
NHS 1 1.03 (0.88, 1.21) 0.98 (0.85, 1.14) 0.97 (0.83, 1.13) 1.15 (0.94, 1.40) 1.05 (0.84, 1.30) 1.10 (0.69, 1.75) 0.45 
NHSII 1 0.89 (0.69, 1.14) 0.99 (0.77, 1.28) 0.83 (0.61, 1.12) 0.65 (0.31, 1.35) 0.70 (0.28, 1.77) 1.16 (0.16, 8.47) 0.19 
HPFS 1 1.01 (0.90, 1.13) 1.00 (0.90, 1.12) 1.02 (0.91, 1.15) 1.05 (0.90, 1.22) 1.06 (0.92, 1.23) 1.06 (0.86, 1.30) 0.33 
Pooled Results 1 1.01 (0.92, 1.10) 1.00 (0.92, 1.08) 0.98 (0.90, 1.07) 1.06 (0.94, 1.19) 1.03 (0.92, 1.16) 1.02 (0.85, 1.23) 0.48 
* 
All results use multivariable model 3 and are adjusted for: age (months), sex (male, female), smoking status (never, former, current), BMI (kg/m
2
: categorical 
<23, 23-<25, 25-<27, 27-<30, 30-<35, 35-<40, 40+), physical activity (MET-hours/week: categorical <3, 3-<9, 9-<18, 18-<27, 27+), oral contraceptive use 
(never, former, current), post-menopausal hormone use (premenopausal, never, former, current), race (Caucasian, other), family history of MI (yes, no), baseline 
high blood cholesterol (yes, no), baseline high blood pressure (yes, no) statin use (yes, no), Alcohol intake (servings/d), multivitamin use (yes, no), total calories 
(per day: quintiles), whole milk (categorical: servings/d), bacon (categorical: servings/d), red meat (categorical: servings/d), other processed meat (categorical: 
servings/d), refined carbohydrates (categorical: servings/d), potatoes (categorical: servings/d), coffee (categorical: servings/d), juice (categorical: servings/d), and 
sugar-sweetened beverages (categorical: servings/d) 
†
P-values for trend based on continuous egg variable derived from the median egg intake in each category of consumption 
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Table 7. Risk of Incident Cardiovascular Disease Subtypes According to Categories of Egg Consumption: Pooled Results
*
 
 Cases/Person 
years, No. 
Frequency of Consumption Categories p-value 
for trend
† 
Outcome <1/month 1-3/month 1/week 2-4/week 5-6/week ≥1/day 
Total Stroke 4,805/4,847,854 1 1.06 (0.94, 1.18) 1.03 (0.92, 1.14) 0.97 (0.86, 1.09) 1.08 (0.88, 1.33) 1.17 (0.96, 1.42) 0.48 
   Ischemic Stroke
 
2,533/4,849,446 1 1.07 (0.91, 1.26) 1.00 (0.86, 1.16) 0.97 (0.82, 1.14) 1.20 (0.91, 1.59) 1.22 (0.94, 1.58) 0.27 
   Hemorrhagic Stroke
 
750/4,851,258 1 1.29 (0.95, 1.75) 1.25 (0.94, 1.67) 1.08 (0.79, 1.48) 0.96 (0.54, 1.70) 0.94 (0.54, 1.63) 0.22 
* 
All results use multivariable model 3 and are adjusted for: age (months), sex (male, female), smoking status (never, former, current), BMI (kg/m
2
: categorical 
<23, 23-<25, 25-<27, 27-<30, 30-<35, 35-<40, 40+), physical activity (MET-hours/week: categorical <3, 3-<9, 9-<18, 18-<27, 27+), oral contraceptive use 
(never, former, current), post-menopausal hormone use (premenopausal, never, former, current), race (Caucasian, other), family history of MI (yes, no), baseline 
high blood cholesterol (yes, no), baseline high blood pressure (yes, no) statin use (yes, no), Alcohol intake (servings/d), multivitamin use (yes, no), total calories 
(per day: quintiles), whole milk (categorical: servings/d), bacon (categorical: servings/d), red meat (categorical: servings/d), other processed meat (categorical: 
servings/d), refined carbohydrates (categorical: servings/d), potatoes (categorical: servings/d), coffee (categorical: servings/d), juice (categorical: servings/d), and 
sugar-sweetened beverages (categorical: servings/d) 
†
P-values for trend based on continuous egg variable derived from the median egg intake in each category of consumption 
!∀#
DISCUSSION 
We observed no overall significant association between egg intake and risk of CVD after 
adjustment for dietary and lifestyle factors. Our observation of an increased risk of CVD when eggs were 
replaced with red and processed meat suggests that red and processed meat is not a healthy replacement 
for egg intakes. However, our results do suggest that substituting low-fat dairy, whole grains, legumes  
and nuts for eggs would result in a lower risk of CVD.  As these foods are associated with a lower risk of 
CVD, consuming them in place of eggs, which do not increase or decrease risk of CVD, would result in a 
net lowered risk of CVD.  
Our results confirm previous analyses of NHSI and HPFS published in 1999, where we did not 
find any significant associations between egg consumption and CVD in either men or women after 
adjusting for both dietary and lifestyle covariates
 6
. In addition, a recent meta-analysis of prospective 
cohort studies found no significant association with egg intake up to one egg per day and risk of total 
CVD
15
. 
Most longitudinal cohort studies have not found any significant association between eggs and 
CVD. However, Djousse et al. found an increased risk of heart failure of 1.28(1.02, 1.61) for those 
consuming 1 egg/day and 1.64(1.08-2.49) for those consuming 2 or more eggs/day in the Physicians’ 
Health Study after adjusting for lifestyle, but not dietary factors 
29
. In a cross-sectional study of patients 
attending a vascular prevention clinic, Spence et al. found that egg consumption was associated with an 
increase in carotid plaque area; however, it is important to note that egg intake was reported 
retrospectively and the authors were not able to adjust for any dietary or lifestyle factors aside from 
smoking, leaving the potential for measurement error and residual confounding
7
. Indeed, several cohort 
studies that were able to adjust for lifestyle and nutrition factors found no association between egg 
consumption up to 1 egg per day and risk of CVD after such adjustment, similar to the current study
 8, 9, 11, 
13, 14, 30
.  
We observed a positive association between egg intake and risk of CVD among participants 
reporting hypertension, while there was no association in participants without hypertension. This suggests 
!!#
that participants at higher risk for CVD may consider reduction of egg consumption.  This relationship 
has not been reported in previous publications; therefore, additional studies will be needed to explore that 
relationship. In our cohorts, we also observed that participants with T2D had a higher risk of CVD, 
similar to the relationship found in previous cohort studies
6, 10
. The meta-analysis mentioned previously 
found a moderately increased risk of CVD among those with T2D in the highest category of egg intake 
compared to the lowest (HR: 1.54; 95% CI: 1.14, 2.09)
15
. It is possible that insulin resistance may 
contribute to altered cholesterol absorption and metabolism
31
. The altered cholesterol absorption seen in 
patients with T2D may increase susceptibility to CVD. In fact, we also observed that a higher percentage 
of participants with T2D reported hypertension and high blood cholesterol than participants without T2D. 
We found no significantly elevated risk of CVD for participants consuming ≥2 eggs per day. 
However, the small number of cases in ≥2 eggs per day category in the current analyses limits drawing a 
strong conclusion from this finding. Previous publications which included a category of ≥2 eggs per day 
included too few cases to conclude any significant associations
9
. 
The current analyses have several strengths, which include repeated measurements of dietary and 
lifestyle variables, high rates of follow-up and a large sample size. The increase in total CVD cases from 
1,124 in the previous publication of these cohorts to 12,832 in the current analyses allows for more robust 
findings in our main results as well as in several sensitivity analyses
6
. The repeated measurement of 
lifestyle variables allows for changes in risk factors over time, while the cumulative average update of 
dietary variables additionally limits random measurement error by accounting for within-person 
differences in intake. We were also able to account for many more dietary and lifestyle covariates than 
previous studies, including variables potentially associated with egg intake such as bacon, red and 
processed meat, coffee, whole milk, juice, sugar sweetened beverages, refined carbohydrates, potatoes 
and French fries.  
This study has some limitations. First, the population consists of health professionals who are 
mostly of European ancestry; however, the education level of participants has likely contributed to the 
reliability and quality of the data collected. Second, there is some measurement error associated with 
!∃#
dietary data collected with the FFQ. Misclassification due to random measurement error in diet could 
result in an underestimation of the association between egg intake and risk of CVD; however, the 
cumulative average update method used for dietary variables reduces random error due to within-person 
variation. In addition, validation studies have found a high de-attenuated correlation for egg intake 
between diet measured through FFQ and 7-day weight records (0.77 for NHS and 0.80 for HPFS) 
20, 21
. 
Third, we were not able to examine the relationship between egg whites or egg substitutes and risk of 
CVD. We recognize the potential for unmeasured or residual confounding, but the ability to adjust for a 
substantial number of dietary and lifestyle limits the likelihood for important unmeasured confounding. 
  In summary, in three large prospective US cohorts egg intake up to one egg per day is overall not 
associated with an increased risk of CVD. However, egg intake was associated with a significantly 
increased risk of CVD among those with hypertension or diabetes. Our analyses also suggest eggs are a 
healthier choice compared to red and processed meats, but that substitution of low-fat dairy, whole grains, 
legumes and nuts for eggs may reduce the risk of CVD. 
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ABSTRACT 
Background 
Due to their high dietary cholesterol content, limiting eggs has been recommended for prevention 
of cardiovascular disease (CVD).  
Objective 
To evaluate the association between egg intake up to 2 eggs per day and the risk of 
Cardiovascular Disease (CVD) mortality in the NIH-AARP Diet and Health study, a large prospective 
cohort. In addition, to perform a meta-analysis of prospective cohort studies of egg intake and risk of 
CVD. 
Methods 
After exclusions, the final population for analysis included 134,731 men and 111,015 women 
without CVD, cancer or type 2 diabetes (T2D) at baseline. Dietary and lifestyle factors including egg 
intake were assessed through two questionnaires at baseline. Cardiovascular disease mortality was 
determined from ICD codes found through linkage to the Social Security Administration Death Master 
File and National Death Index. Deaths through December 13st, 2011 were included in the analysis. 
Multivariate cox proportional hazards models were used to estimate relative risks (HR) and 95% 
confidence intervals (CI).  An updated meta-analysis of the current literature was also conducted. 
Results 
We identified 11,268 cases of CVD mortality. We observed the following risk of CVD mortality 
with egg intake (HR(95%CI) by category: 0-1/month: 1(Ref); 2-3/month: 0.94 (0.89, 1.00); 1-2/week: 
0.99 (0.93, 1.04); 3-4/week: 1.04 (0.97, 1.10); 5-6/week: 1.08 (0.97, 1.19); 1/day: 1.23 (1.06, 1.42);  
≥2/day: 1.14 (0.95, 1.36); p-trend<0.001). For each increase of one egg per day we found that the risk of 
CVD mortality was (HR: 1.12, 95% CI: (1.05, 1.20)). Among participants with T2D, there was an 
increased risk of CVD mortality for each increase of one egg per day, with HR: 1.25 (1.11, 1.41). Our 
updated meta-analysis, which includes 630,786 participants and 28,139 cases of CVD, found a small 
increased risk of CVD with increases in egg intake of 1 egg per day in the fixed-effect model (HR: 1.05; 
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95% CI(1.01, 1.09), p-value for heterogeneity=0.052). Among participants with T2D a fixed effects meta-
analysis found an increased risk of CVD for an increase in consumption of 1 egg per day with HR: 1.24 
(1.12, 1.37) (p-value for heterogeneity=0.78). 
Conclusions 
Higher egg intake was associated with a modestly increased risk of CVD after adjustment for 
lifestyle factors in the AARP Study and meta-analysis. There was a significant positive association 
between egg intake and risk of CVD among participants with T2D.  
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INTRODUCTION 
Cardiovascular disease is the leading cause of death worldwide.
24
 Dietary and lifestyle factors 
play a large part in the incidence and progression of the disease.
1
 In the past, decreases in egg 
consumption have been recommended due to the cholesterol contained in eggs (about 200g).
1
 However, 
dietary cholesterol does not have as large of an effect on blood cholesterol levels as other dietary factors 
such as saturated and unsaturated fats.
44, 45
 The 2013 AHA/ACC report concluded that there was 
“insufficient evidence to determine whether lowering dietary cholesterol reduces LDL-C
46
. In addition, 
the 2015 Dietary Guidelines Advisory Committee did not carry forward the recommendations of an upper 
limit for dietary cholesterol.
3
 In addition, eggs contain a number of other beneficial nutrients such as B-
vitamins and unsaturated fat
4
.  
Recent articles have linked egg intake to risk factors for cardiovascular disease. A cross-sectional 
study of vascular prevention clinic patients found an increase in atherosclerotic plaque area with 
increasing egg consumption.
7
 In addition, recent research on gut microbiota has found a link between 
higher levels of TMAO, a metabolite of lecithin which is found in egg yolks, and CVD in at risk 
patients.
47
  
Although these studies and others have sparked debate, several prospective studies of egg 
consumption have found no material increased risk of CVD. A recent meta-analysis found that an 
increase in consumption of one egg per day did not increase the risk of coronary heart disease (CHD) 
(HR: 0.99; 95% CI:((0.85, 1.15)) or stroke (HR: 0.91; 95% CI:(0.81, 1.02)).
27
 Additionally, an updated 
analysis of the Nurses’ Health and Health Professionals Follow-up Studies did not find a significantly 
increased risk of incident CVD with egg consumption of one or more eggs per day (HR: 1.10; 95% 
CI:(0.98, 1.23)).
48
 Several other studies found no increased risk of either stroke or CHD mortality with 
increasing egg intake.
10, 12, 13
  
The aim of the current analysis is to determine the relationship between egg intake and risk of 
CVD in an older population at risk for CVD.  The large sample size allows us to examine egg intake of 2 
!)#
or more eggs per day, whereas most previous publications have only been able to determine risk for 1 egg 
per day or less.   
 
METHODS 
The NIH-AARP Diet and Health Study is a prospective cohort study that began in 1995 and 
included members of the AARP living in six U.S. states (California, Florida, Pennsylvania, New Jersey, 
North Carolina or Louisiana) and two metropolitan areas (Atlanta, Georgia and Detroit, Michigan). 
Baseline questionnaires collected self-report information on diet and lifestyle factors on 567,169 
participants. Diet was collected through validated semi-quantitative FFQ. The FFQ was compared to 24-
hour recalls from a subset of 1,415 patients and correlations between the individual foods in the FFQ and 
24-hour recalls ranged from 0.42 for fiber to 0.70 for red meat.
49
 The correlation between the FFQ and 
24-hour recalls for dietary cholesterol was 0.68 for both men and women
50
. An additional survey was 
completed by 334,906 of the baseline participants and included risk factor information such as medication 
use, physical activity and family history of disease in 1996.  
 
Assessment of Egg Intake 
Egg intake was reported with the baseline validated semi-quantitative FFQ in 1995. Participants 
were asked on average how many eggs, of any type, they consumed in the past 12 months in categories 
ranging from never to two or more times per day. Participants were additionally asked what type of egg 
they normally consumed (whole, egg whites or egg substitutes) and the usual cooking method. Total 
number of eggs consumed was evenly divided between each of the egg types reported (whole, egg whites 
or egg substitutes) to calculate the final whole egg intake variable. Reported intake includes whole eggs 
prepared separately from other foods. Egg intake was analyzed in categories of 0-1 per month, 2-3 per 
month, 1-2 per week, 3-4 per week, 5-6 per week, 1 per day and ≥2 per day. 
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Assessment of CVD Mortality 
Mortality was determined through linkage to the Social Security Administration Death Master 
File (SSA DMF) and through searches of the National Death Index (NDI). Cause of death was determined 
through death certificate ICD codes that were further grouped into National Cancer Institute Surveillance 
Epidemiology and End Results (SEER) codes. Cardiovascular disease mortality includes the following 
categories: diseases of heart, hypertension without heart disease, cerebrovascular diseases, 
atherosclerosis, aortic aneurysm and dissection, and other diseases of arteries, arterioles and capillaries.  
 
Statistical Methods 
Participants were excluded if they used a proxy to complete questionnaires (n=19,139), reported 
prevalent cancer at baseline (n=4,551), did not complete the risk factor questionnaire or left the study 
before returning the risk factor questionnaire (n= 222,660), reported diabetes (n=27,468), heart disease 
(n=36,386) or stroke (n=3,286) at baseline, or if BMI was missing (n=5,059). Unrealistic total energy 
intake was determined by calculating the interquartile range from the first to third quartile of the Box-Cox 
normally transformed total energy variable
51
. Any values less than two times the interquartile range below 
the first quartile or above the third quartile were excluded (n=1,999). The final sample for analysis 
included 245,746 participants (134,731 men and 111,015 women). Covariates that were considered as 
possible confounders for use in multivariate analysis include: age, race/ethnicity, education, BMI, 
smoking status, physical activity, diabetes history, family history of CVD, self-reported health, 
hypertension, alcohol consumption, multivitamin use, total energy intake and for women; postmenopausal 
status, use of menopausal hormones, and use of oral contraceptives. In addition, an overall healthy diet 
(aHEI), western dietary pattern, glycemic load, and foods associated with egg intake (e.g. bacon, red 
meat, other processed meats, refined carbohydrates, potatoes, whole milk, juice, sugar-sweetened 
beverages and coffee) were considered as possible confounders. For missing covariates, a missing 
indicator category was created and included in the model. Total energy intake was included in the final 
model to control for confounding and reduce extraneous variation due to body size, physical activity and 
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metabolic efficiency. Hazard ratios and 95% confidence intervals were calculated using multivariate 
adjusted Cox proportional Hazards analyses for incident CVD mortality. Person time was calculated from 
the date of return of the risk factor questionnaire in 1996 until death or the end of follow-up on December 
31, 2011. Stratified analyses and likelihood ratio tests for interactions were conducted for age, sex, race, 
BMI, physical activity, smoking status, baseline hypertension, baseline high blood cholesterol and egg 
cooking method.  
In sensitivity analyses, eggs including egg whites or substitutes and total eggs (including eggs 
from mixed dishes) were analyzed separately as exposure variables. To examine the possibility of recall 
bias due to changes in disease status, we conducted secondary analyses for the population including those 
with CVD and T2D at baseline. The proportional hazards assumption was confirmed through a likelihood 
ratio test of a model including of a time to event interaction term and a model without the interaction term 
(p-value=0.07).   
Additionally, the recent meta-analysis by Rong et al. was updated to include the current results.
27
 
PubMed and Embase were searched through June 2015 using the following key words: “Cardiovascular 
diseases” MeSH, CVD, coronary heart disease, CHD, “Coronary disease” MeSH, “myocardial infarction” 
MeSH, MI,  “Stroke” MeSH and egg. Relative risks for one egg per day were calculated for each study 
using the trend for log relative risks of egg intake categories, accounting for correlated estimates.
38, 52
 
Dose of egg consumption was the median of each category or midpoint of the upper and lower bound of 
each egg category. If HRs 95% CIs and person-years were not available, summary statistics were used 
based on the highest category of egg consumption compared to the lowest. We examined heterogeneity 
using the Cochran Q test and I
2
 statistic. We used fixed effects when heterogeneity between studies was 
low and random effects when heterogeneity was high. All p-values are 2-sided. Statistical analyses for the 
meta-analysis were performed using Stata v.12 (StataCorp, College Station, Tx).  All other statistical 
analyses were performed using SAS v.9.3 (SAS Institute, Inc., Cary, NC). 
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RESULTS 
After all exclusions, there were 245,746 participants and 11,268 cases of CVD mortality in the 
final sample. Higher egg intake at baseline was associated with higher BMI, number of participants 
reporting high blood cholesterol, total energy, and intake of bacon, red meat, other processed meats, 
coffee and sugar-sweetened beverages in both men and women. Higher egg intake was also associated 
with lower education level, less married participants, more smokers and lower levels of physical activity 
in men and women. Additionally, higher egg consumption was associated with increased percentage of 
participants with a family history of T2D, lower multivitamin use, higher intake of refined carbohydrate 
and whole milk in men, and a lower percentage of participants with a family history of T2D in women 
(Table 8).  
In analyses adjusted only for age, higher egg consumption was associated with a significantly 
increased risk of CVD mortality (1/day HR: 1.84, 95% CI(1.59, 2.13); ≥2/day HR: 2.14, 95% CI(1.80, 
2.54); p-trend<0.001) (Table 9). However, after adjustment for diet and lifestyle factors, results were 
substantially attenuated (1/day HR: 1.23, 95% CI(1.06, 1.42); ≥2/day HR: 1.14, 95% CI(0.95, 1.36); p-
trend<0.001). After multivariate adjustment, every increase of one egg per day was associated with an 
increased risk of CVD mortality of HR: 1.12, 95% CI(1.05, 1.20). A significant interaction was found for 
race (p=0.01), with a relatively greater increased risk of CVD mortality as egg consumption increased for 
non-whites compared to whites (Table 10).  No other significant interactions were found for age, sex, 
BMI, physical activity, smoking status, hypertension, high blood cholesterol, or egg cooking method. 
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Table 8: Baseline Age-Standardized Characteristics According to Whole Egg Consumption Levels 
 Whole Egg Intake 
 Women Men 
 0-1/month 3-4/week ≥2/day 0-1/month 3-4/week ≥2/day 
Participants, No 36,881 11,529 361 34,004 22,408 1,380 
Age, mean, y 62.6 62.3 61.8 62.7 62.7 62.6 
Body mass Index, mean
*
 25.7 27.4 28.5 26.1 27.6 28.2 
White race, % 91 92 93 93 94 91 
Some college education, % 60 58 52 76 66 56 
Married, % 46 44 43 83 84 77 
Smoking Status       
   Never smoker, % 45 41 29 37 27 21 
   Past smoker, % 41 37 42 54 56 53 
   Current smoker, % 10 18 24 5 14 23 
Current Physical Activity >1/month, % 68 62 24 77 71 65 
Current menopausal hormone use, %
 
47 46 39    
Postmenopausal, %
 
95 95 94    
Oral contraceptive use >1yr, %
 
39 42 39    
Self-reported Good Health Status, % 91 89 88 94 92 87 
Multivitamin use ≥1/wk, % 56 54 60 50 45 45 
Hypertension, % 32 35 33 35 36 34 
High Blood Cholesterol, % 42 56 68 37 52 61 
Family History of Diabetes, % 28 28 31 23 25 27 
Dietary Intake, mean       
   Total energy, kcal/day 1420 1825 2027 1825 2289 2702 
   Alcohol, serv/day 0.4 0.6 0.4 1.1 1.6 1.6 
   Bacon, oz/day 0.0 0.0 0.1 0.0 0.1 0.2 
   Red meat, oz/d 1.0 1.9 2.5 1.7 3.1 3.9 
   Other processed meat, oz/day 0.4 0.5 0.7 0.6 1.0 1.2 
   Refined carbohydrates products, oz/day 3.4 4.1 3.8 4.4 4.9 5.3 
   Potatoes, oz/day 0.3 0.4 0.4 0.4 0.5 0.6 
   Whole milk, cups/day 0.0 0.1 0.2 0.1 0.2 0.4 
   Coffee, cups/day 2.8 3.4 3.6 3.0 3.9 4.6 
   Juice, cups/day 0.7 0.7 0.7 0.9 0.8 0.8 
   Sugar-sweetened beverages, oz/day 0.2 0.3 0.5 0.3 0.6 0.8 
Abbreviations: Number (No), Year (y), week (wk), servings (serv), ounces (oz), grams (g) 
*
Body mass index calculated as weight in kilograms divided by height in meters squared 
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Table 9:  Cardiovascular Disease Mortality According to Categories of Whole Egg Consumption 
 Frequency of Consumption Categories 
p-trend 
HR (95%CI) 
for increase of 
1 egg/day 
Variable 0-1/month 2-3/month 1-2/week 3-4/week 5-6/week 1/day ≥2/day 
Cases, No. 2,967 2,250 3,331 1,866 526 193 135  11,268 
Person years, No. 953,762 736,142 980,815 445,855 105,250 34,284 21,977  3,278,085 
Age adjusted model 1 1 1.02 (0.96, 1.07) 1.11 (1.06, 1.17) 1.38 (1.31, 1.47) 1.71 (1.56, 1.87) 1.84 (1.59, 2.13) 2.14 (1.80, 2.54) <0.001 1.70 (1.61, 1.80) 
Multivariable model 2
* 
1 0.96 (0.90, 1.01) 1.01 (0.96, 1.06) 1.09 (1.02, 1.15) 1.16 (1.05, 1.27) 1.33 (1.15, 1.54) 1.28 (1.07, 1.52) <0.001 1.21 (1.14, 1.29) 
Multivariable model 3
† 
1 0.94 (0.89, 1.00) 0.99 (0.93, 1.04) 1.04 (0.97, 1.10) 1.08 (0.97, 1.19) 1.23 (1.06, 1.42) 1.14 (0.95, 1.36) <0.001 1.13 (1.05, 1.20) 
*
Multivariable model 2 includes: age (years), sex, race (Caucasian, non-Hispanic black, other), education (high school, some college, college, unknown), 
marriage status (married, widowed, divorced, separated, never married, unknown), BMI (kg/m
2
: categorical <23, 23-<25, 25-<27, 27-<30, 30-<35, 35-<40, ≥40), 
smoking dose (never, past, current: 1-19/d, current: ≥20/d, unknown), physical activity (≥20 minutes: categorical  never, rarely, 1-3/mo, 1-2/wk, 3-4/wk, ≥5/wk, 
unknown), menopausal status (pre, post-menopausal unknown), post-menopausal hormone use (never, former, current, unknown), oral contraceptive use (years: 
categorical 0, 1-4, 5-9, ≥10, unknown), self-reported health status (excellent, very good, good, fair, poor, unknown), baseline hypertension (yes, no), baseline 
high blood cholesterol (yes, no), alcohol intake (servings/day: quintiles), multivitamin use (never, <1/wk, 1-3/wk, 4-6/wk, daily, unknown) 
†
Multivariable model 3 includes: 
 
model 2 with total calories (per day), bacon (servings/d: quintiles), red meat (servings/d: quintiles), other processed meat 
(servings/d: quintiles), refined carbohydrates (servings/d: quintiles), potatoes (servings/d: quintiles), whole milk (servings/d: quartiles), coffee (servings/d: 
quintiles),  juice (servings/d: quintiles), sugar-sweetened beverages (servings/d: quintiles) 
 
 
 
 
 
 
 
 
 
 
 
 
 
!∃#
Table 10.  Stratified Analysis of Cardiovascular Disease Mortality According to Categories of Whole Egg Consumption
*
 
 Frequency of Consumption Categories  
Variable 0-1/month 2-3/month 1-2/week 3-4/week 5-6/week 1/day ≥2/day 
p-
trend
†
 
Age < 70 1 0.93 (0.87, 0.98) 0.98 (0.92, 1.04) 1.03 (0.96, 1.10) 1.08 (0.97, 1.40) 1.25 (1.07, 1.46) 1.17 (0.97, 1.40) <0.001 
Age ≥ 70 1 1.04 (0.90, 1.20) 1.02 (0.89, 1.18) 1.05 (0.88, 1.25) 1.05 (0.78, 1.41) 1.08 (0.70, 1.66) 0.91 (0.51, 1.63) 0.84 
   
Male 1 0.91 (0.85, 0.98) 0.97 (0.91, 1.04) 1.03 (0.96, 1.12) 1.07 (0.95, 1.20) 1.20 (1.00, 1.43) 1.07 (0.88, 1.31) 0.007 
Female 1 0.98 (0.90, 1.07) 1.00 (0.92, 1.09) 1.02 (0.91, 1.15) 1.07 (0.86, 1.31) 1.32 (1.00, 1.75) 1.48 (0.98, 2.25) 0.03 
         
White 1 0.92 (0.87, 0.98) 0.97 (0.92, 1.03) 1.02 (0.95, 1.09) 1.03 (0.92, 1.14) 1.16 (0.99, 1.36) 1.12 (0.93, 1.35) 0.009 
Other 1 1.18 (0.95, 1.45) 1.13 (0.92, 1.39) 1.24 (0.98, 1.57) 1.74 (1.26, 2.41) 1.91 (1.24, 2.94) 1.35 (0.74, 2.47) 0.004 
   
BMI < 30 1 0.93 (0.87, 0.99) 0.99 (0.93, 1.06) 1.05 (0.98, 1.13) 1.03 (0.91, 1.17) 1.20 (1.00, 1.43) 1.15 (0.92, 1.43) 0.009 
BMI ≥ 30 1 0.98 (0.87, 1.10) 0.96 (0.86, 1.07) 1.01 (0.89, 1.14) 1.20 (1.01, 1.42) 1.35 (1.02, 1.78) 1.19 (0.88, 1.60) 0.01 
   
< 20 min/wk PA 1 1.01 (0.92, 1.11) 1.02 (0.93, 1.11) 1.14 (1.02, 1.26) 1.19 (1.02, 1.38) 1.33 (1.06, 1.68) 1.16 (0.88, 1.53) 0.002 
≥ 20 min/wk PA 1 0.91 (0.85, 0.97) 0.97 (0.91, 1.04) 0.98 (0.90, 1.06) 1.01 (0.89, 1.15) 1.16 (0.96, 1.41) 1.13 (0.89, 1.42) 0.07 
         
Non-smoker 1 0.94 (0.89, 1.00) 0.98 (0.93, 1.04) 1.02 (0.95, 1.09) 1.10 (0.98, 1.23) 1.22 (1.03, 1.45) 1.18 (0.96, 1.45) 0.002 
Current smoker 1 0.92 (0.81, 1.06) 1.00 (0.88, 1.14) 1.09 (0.94, 1.26) 1.03 (0.84, 1.26) 1.25 (0.92, 1.69) 1.08 (0.77, 1.52) 0.10 
         
No hypertension 1 0.93 (0.86, 1.00) 0.97 (0.90, 1.05) 1.02 (0.94, 1.12) 1.04 (0.91, 1.19) 1.21 (0.99, 1.49) 1.03 (0.80, 1.31) 0.09 
Hypertension 1 0.96 (0.89, 1.04) 1.00 (0.92, 1.08) 1.05 (0.96, 1.15) 1.11 (0.97, 1.28) 1.24 (0.99, 1.54) 1.28 (0.99, 1.65) 0.002 
         
Normal blood cholesterol 1 0.96 (0.89, 1.04) 1.01 (0.95, 1.09) 1.06 (0.97, 1.15) 1.03 (0.89, 1.19) 1.16 (0.92, 1.46) 1.11 (0.85, 1.47) 0.07 
High blood cholesterol 1 0.93 (0.85, 1.01) 0.96 (0.88, 1.05) 1.02 (0.93, 1.13) 1.14 (0.99, 1.31) 1.30 (1.07, 1.58) 1.18 (0.93, 1.49) <0.001 
         
Cooked without fat 1 0.98 (0.91, 1.05) 0.99 (0.92, 1.06) 1.04 (0.95, 1.13) 1.11 (0.95, 1.29) 1.14 (0.91, 1.43) 1.02 (0.75, 1.37) 0.16 
Cooked with added fat 1 0.93 (0.85, 1.02) 1.00 (0.92, 1.10) 1.06 (0.96, 1.17) 1.08 (0.94, 1.24) 1.32 (1.08, 1.62) 1.24 (0.99, 1.55) <0.001 
* 
All results are from multivariable model 3 and include: age (years), sex, race (Caucasian, non-Hispanic black, other), education (high school, some college, 
college, unknown), marriage status (married, widowed, divorced, separated, never married, unknown), BMI (kg/m
2
: categorical <23, 23-<25, 25-<27, 27-<30, 
30-<35, 35-<40, ≥40), smoking dose (never, past, current: 1-19/d, current: ≥20/d, unknown), physical activity (≥20 minutes: categorical  never, rarely, 1-3/mo, 1-
2/wk, 3-4/wk, ≥5/wk, unknown), menopausal status (pre, post-menopausal unknown), post-menopausal hormone use (never, former, current, unknown), oral 
contraceptive use (years: categorical 0, 1-4, 5-9, ≥10, unknown), self-reported health status (excellent, very good, good, fair, poor, unknown), hypertension (yes, 
no), high blood cholesterol (yes, no), alcohol intake (servings/day: quintiles), multivitamin use (never, <1/wk, 1-3/wk, 4-6/wk, daily, unknown), total calories 
(per day), bacon (servings/d: quintiles), red meat (servings/d: quintiles), other processed meat (servings/d: quintiles), refined carbohydrates (servings/d: 
quintiles), potatoes (servings/d: quintiles), whole milk (servings/d: quartiles), coffee (servings/d: quintiles),  juice (servings/d: quintiles), sugar-sweetened 
beverages (servings/d: quintiles) 
!%#
Table 10 (Continued) 
  HR (95% CI) 
for increase of 1 
egg/day 
p-int
‡
 
Variable 
Cases 
Age < 70 9,640/3,072,301 1.14 (1.06, 1.22) 0.40 
Age ≥ 70 1,628/205,784 1.02 (0.84, 1.24)  
    
Male 7,256/1,776,763 1.11 (1.03, 1.20) 0.50 
Female 4,012/1,501,322 1.17 (1.02, 1.34)  
    
White 10,489/3,049,639 1.10 (1.02, 1.18) 0.01 
Other 779/228,446 1.38 (1.11, 1,71)  
    
BMI < 30 8,458/2,669,482 1.15 (1.04, 1.29) 0.58 
BMI ≥ 30 2,810/608,603 1.24 (1.05, 1.47)  
    
< 20 min/wk PA 4,099/972,807 1.18 (1.06, 1.30) 0.31 
≥ 20 min/wk PA 7,169/2,305,278 1.09 (0.99, 1.19)  
    
Non-smoker 8,170/2,012,144 1.13 (1.05, 1.22) 0.62 
Current smoker 3,098/1,265,941 1.12 (0.98, 1.28)  
    
No hypertension 5,734/2,187,406 1.08 (0.99, 1.19) 0.67 
Hypertension 5,534/1,090,679 1.17 (1.06, 1.29)  
    
Normal blood cholesterol 6,296/1,714,305 1.10 (0.99, 1.21) 0.51 
High blood cholesterol 4,972/1,563,780 1.17 (1.07, 1.28)  
    
Cooked without fat 5,876/1,712,711 1.08 (0.97, 1.19) 0.76 
Cooked with added fat 5,401/1,565,374 1.18 (1.08, 1.30)  
†
P-values for trend based on continuous egg variable derived from the median egg intake in each category of consumption 
‡
P-values for interaction calculated using the likelihood ratio test 
!∀#
In sensitivity analyses we observed a relatively higher increased risk of CVD mortality in those 
consuming two or more eggs per day who reported having T2D at baseline (HR: 1.53, 95% CI: (1.15, 
2.03)) compared to those who had no T2D or CVD at baseline (HR: 1.14, 95% CI: (0.95, 1.36), p-value 
for interaction=0.63) (Table 11). We also saw an increased risk of CVD mortality for two or more eggs 
per day in those who reported both baseline CVD and T2D (HR: 1.60, 95% CI(1.12, 2.29)). However, for 
those reporting CVD without T2D at baseline, the corresponding HR (95% CI) was 0.66 (0.44, 1.00). We 
observed no significant differences in risk of CVD mortality when we limited follow-up time to 5 or to 10 
years to explore the possibility of misclassification due to baseline collection of dietary intakes (data not 
shown). Compared to whole eggs, the inclusion of eggs from all sources was associated with a similar 
risk of CVD mortality (HR for an increase of 1 egg/day: 1.11, 95% CI(1.04, 1.19))(Table 12), as was the 
inclusion of egg whites and egg substitutes with whole eggs as the exposure (HR for an increase of 1 
egg/day: 1.13, 95% CI(1.06, 1.21)) (Table 13). 
!∀#
Table 11. Cardiovascular Disease Mortality According to Categories of Whole Egg Consumption Including Participants who Reported Heart 
Disease, Stroke or Type 2 Diabetes at Baseline
* 
 No baseline T2D or CVD Baseline T2D Only Baseline CVD Only Baseline T2D and CVD 
Cases/Person years, No.
 
11,268/3,278,085 2,174/223,269 6,186/470,900 2,323/85,307 
Frequency of Consumption Categories     
   0-1/month 1 1 1 1 
   2-3/month 0.94 (0.89, 1.00) 1.07 (0.93, 1.22) 0.99 (0.91, 1.06) 0.95 (0.84, 1.08) 
   1-2/week 0.99 (0.93, 1.04) 1.04 (0.92, 1.19) 1.00 (0.93, 1.07) 1.00 (0.93, 1.07) 
   3-4/week 1.00 (0.93, 1.07) 1.21 (1.05, 1.39) 1.06 (0.97, 1.16) 1.05 (0.92, 1.20) 
   5-6/week 1.08 (0.97, 1.19) 1.18 (0.97, 1.45) 1.05 (0.90, 1.23) 1.13 (0.92, 1.39) 
   1/day 1.23 (1.06, 1.42) 1.28 (0.97, 1.69) 0.98 (0.74, 1.28) 1.13 (0.82, 1.57) 
   ≥2/day 1.14 (0.95, 1.36) 1.53 (1.15, 2.03) 0.66 (0.44, 1.00) 1.60 (1.12, 2.29) 
p-trend
†
 <0.001 <0.001 0.73 0.004 
HR (95% CI) for increase of 1 egg/day 1.13 (1.05, 1.20) 1.25 (1.11, 1.41) 0.98 (0.88, 1.10) 1.23 (1.07, 1.42) 
* 
All results are from multivariable model 3 and include: age (years), sex, race (Caucasian, non-Hispanic black, other), education (high school, some college, college, unknown), 
marriage status (married, widowed, divorced, separated, never married, unknown), BMI (kg/m
2
: categorical <23, 23-<25, 25-<27, 27-<30, 30-<35, 35-<40, ≥40), smoking dose 
(never, past, current: 1-19/d, current: ≥20/d, unknown), physical activity (≥20 minutes: categorical  never, rarely, 1-3/mo, 1-2/wk, 3-4/wk, ≥5/wk, unknown), menopausal status 
(pre, post-menopausal unknown), post-menopausal hormone use (never, former, current, unknown), oral contraceptive use (years: categorical 0, 1-4, 5-9, ≥10, unknown), self-
reported health status (excellent, very good, good, fair, poor, unknown), hypertension (yes, no), high blood cholesterol (yes, no), alcohol intake (servings/day: quintiles), 
multivitamin use (never, <1/wk, 1-3/wk, 4-6/wk, daily, unknown), total calories (per day), bacon (servings/d: quintiles), red meat (servings/d: quintiles), other processed meat 
(servings/d: quintiles), refined carbohydrates (servings/d: quintiles), potatoes (servings/d: quintiles), whole milk (servings/d: quartiles), coffee (servings/d: quintiles),  juice 
(servings/d: quintiles), sugar-sweetened beverages (servings/d: quintiles) 
†
P-values for trend based on continuous egg variable derived from the median egg intake in each category of consumption 
 
Table 12. Cardiovascular Disease Mortality According to Categories of Egg Consumption from Whole Eggs and Eggs in Mixed Dishes 
 Frequency of Consumption Categories 
p-trend
†
 
HR (95% CI) 
for increase of 
1 egg/day 
Variable 0-1/month 2-3/month 1-2/week 3-4/week 5-6/week 1/day ≥2/day 
Cases, No. 357 1,267 5,663 2,203 1,105 537 136  11,268 
Person years, No. 101,360 417,784 1,802,436 595,236 239,933 99,280 22,056  3,278,085 
Multivariable model 3
*
 1 0.90 (0.80, 1.01) 0.90 (0.80, 1.01) 0.91 (0.80, 1.03) 1.00 (0.88, 1.15) 1.05 (0.90, 1.22) 1.04 (0.85, 1.28) 0.003 1.11 (1.04, 1.18) 
*Results are from multivariable model 3 and include: age (years), sex, race (Caucasian, non-Hispanic black, other), education (high school, some college, college, unknown), 
marriage status (married, widowed, divorced, separated, never married, unknown), BMI (kg/m
2
: categorical <23, 23-<25, 25-<27, 27-<30, 30-<35, 35-<40, ≥40), smoking dose 
(never, past, current: 1-19/d, current: ≥20/d, unknown), physical activity (≥20 minutes: categorical  never, rarely, 1-3/mo, 1-2/wk, 3-4/wk, ≥5/wk, unknown), menopausal status 
(pre, post-menopausal unknown), post-menopausal hormone use (never, former, current, unknown), oral contraceptive use (years: categorical 0, 1-4, 5-9, ≥10, unknown), self-
reported health status (excellent, very good, good, fair, poor, unknown), hypertension (yes, no), high blood cholesterol (yes, no), alcohol intake (servings/day: quintiles), 
multivitamin use (never, <1/wk, 1-3/wk, 4-6/wk, daily, unknown), total calories (per day), bacon (servings/d: quintiles), red meat (servings/d: quintiles), other processed meat 
(servings/d: quintiles), refined carbohydrates (servings/d: quintiles), potatoes (servings/d: quintiles), whole milk (servings/d: quartiles), coffee (servings/d: quintiles),  juice 
(servings/d: quintiles), sugar-sweetened beverages (servings/d: quintiles) 
†
P-values for trend based on continuous egg variable derived from the median egg intake in each category of consumption 
 
 
!∃#
Table 13. Cardiovascular Disease Mortality According to Categories of Egg Consumption Including Whole Eggs, Egg Whites and Egg Substitutes 
 Frequency of Consumption Categories 
p-
trend
†
 
HR (95% CI) 
for increase of 1 
egg/day 
Variable 0-1/month 2-3/month 1-2/week 3-4/week 5-6/week 1/day ≥2/day 
Cases, No. 2,060 2,536 3,674 2,037 582 219 160  11,268 
Person years, No. 658,549 845,207 1,094,632 493,873 118,549 40,217 27,059  3,278,085 
Multivariable model 3
a
 1 0.94 (0.88, 0.99) 0.98 (0.93, 1.04) 1.02 (0.96, 1.10) 1.06 (0.97, 1.17) 1.21 (1.05, 1.39) 1.14 (0.97, 1.35) 0.003 1.13 (1.06, 1.20) 
a 
Results are from multivariable model 3 and include: age (years), sex, race (Caucasian, non-Hispanic black, other), education (high school, some college, college, unknown), 
marriage status (married, widowed, divorced, separated, never married, unknown), BMI (kg/m
2
: categorical <23, 23-<25, 25-<27, 27-<30, 30-<35, 35-<40, ≥40), smoking dose 
(never, past, current: 1-19/d, current: ≥20/d, unknown), physical activity (≥20 minutes: categorical  never, rarely, 1-3/mo, 1-2/wk, 3-4/wk, ≥5/wk, unknown), menopausal status 
(pre, post-menopausal unknown), post-menopausal hormone use (never, former, current, unknown), oral contraceptive use (years: categorical 0, 1-4, 5-9, ≥10, unknown), self-
reported health status (excellent, very good, good, fair, poor, unknown), hypertension (yes, no), high blood cholesterol (yes, no), alcohol intake (servings/day: quintiles), 
multivitamin use (never, <1/wk, 1-3/wk, 4-6/wk, daily, unknown), total calories (per day), bacon (servings/d: quintiles), red meat (servings/d: quintiles), other processed meat 
(servings/d: quintiles), refined carbohydrates (servings/d: quintiles), potatoes (servings/d: quintiles), whole milk (servings/d: quartiles), coffee (servings/d: quintiles),  juice 
(servings/d: quintiles), sugar-sweetened beverages (servings/d: quintiles) 
†
P-values for trend based on continuous egg variable derived from the median egg intake in each category of consumption 
 
 
 
 
 
 
 
 
 
 
 
!∀#
In the updated meta-analysis we retrieved 1,660 articles from the preliminary search. After 
review of the articles, 1,630 were eliminated if they did not mention CVD or eggs, and 24 were excluded 
after full text review due to being reviews or commentaries, not including CVD as the outcome, not 
including sufficient data for meta-analysis or if they were previous publications of studies that were 
already included in the meta analysis (Figure 3).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. Meta-analysis Search Strategy and Study Selection 
 
 
1,660 articles identified from search 
 
30 full text articles reviewed 
6 articles included in meta-analysis 
 4 studies examined both Coronary Heart Disease and Stroke 
 1 study examined Coronary Heart Disease only 
 1 study examined Stroke only 
1,630 articles excluded that did not mention 
both egg intake and Cardiovascular Disease 
24 articles excluded 
 9 review articles 
 5 commentaries 
 6 articles without CVD as the outcome 
 2 articles without HR and 95% CI or case numbers 
2 articles from same study sample as later 
published work 
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Table 14. Meta-analysis Study Characteristics 
Study Population Country sex Age at 
baseline 
# participants mean 
follow-
up 
Case ascertainment 
Sauvaget, 
2003 
Hiroshima/Nagasaki 
Life Span Study 
Japan Male 
and 
Female 
34-103 34807 16-17 Confirmed by nationwide family 
registration system  
Nakamura, 
2004 
NIPPON DATA80 Japan Male 30+ 4077 14 Confirmed by National Vital 
Statistics  
Female 30+ 5186 14 Confirmed by National Vital 
Statistics  
Nakamura, 
2006 
Japan Public Health 
Center-based 
prospective study 
Japan Male 
and 
Female 
40-69 90735 10.2 Confirmed by medical records, 
letter, telephone or death 
certificate  
Quershi, 
2007 
NHANES-I USA Male 
and 
Female 
25-74 9734 20 Confirmed by medical records or 
death certificate  
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Table 14 (Continued) 
Study Population Endpoints Relative risks Covariates in fully adjusted 
model 
Sauvaget, 
2003 
Hiroshima/Nagasaki 
Life Span Study 
stroke mortality 
(1259) 
Never, 1.0 (reference); ≤1 egg/week*, 0.74 (0.55 to 
1.00); 2-4 eggs/week, 0.78 (0.59 to 1.04); almost 
daily, 0.72 (0.54 to 0.97)  
Age, sex, birth cohort, city, radiation 
dose, body mass index, smoking, 
alcohol habits, education level, history 
of diabetes, or hypertension 
Nakamura, 
2004 
NIPPON DATA80 Ischemic heart 
disease mortality 
(39) 
Ischemic heart disease mortality: seldom, 1.18 (0.26 
to 5.42); 1-2 eggs/week, 1.71 (0.78 to 3.76); 0.5 
eggs/day, 1.49 (0.63 to 3.48); 1 egg/day, 1.0 
(reference)  
Age, serum creatinine, total 
cholesterol, blood glucose, body mass 
index, blood pressures, use of blood 
pressure lowering drugs, smoking, and 
alcohol intake 
stroke mortality 
(112) 
Stroke mortality: seldom, 0.93 (0.36 to 2.40); 1-2 
eggs/week, 1.09 (0.69 to 1.72); 0.5 eggs/day, 1.10 
(0.68 to 1.76); 1 egg/day, 1.0 (reference); ≥2 
eggs/day, 0.25 (0.03 to 1.81)  
Ischemic heart 
disease mortality 
(41) 
Ischemic heart disease mortality: seldom, 1.42 (0.56 
to 3.62); 1-2 eggs/week, 0.64 (0.28 to 1.44); 0.5 
eggs/day, 0.78 (0.35 to 1.82); 1 egg/day, 1.0 
(reference);  
Age, serum creatinine, total 
cholesterol, blood glucose, body mass 
index, blood pressures, use of blood 
pressure lowering drugs, smoking, and 
alcohol intake 
stroke mortality 
(107) 
Stroke mortality: seldom, 0.78 (0.35 to 1.73); 1-2 
eggs/week, 0.79 (0.47 to 1.33); 0.5 eggs/day, 1.46 
(0.89 to 2.4); 1 egg/day, 1.0 (reference); ≥2 eggs/day, 
1.22 (0.29 to 5.17) ≥2 eggs/day, 1.27 (0.16 to 9.80)  
Nakamura, 
2006 
Japan Public Health 
Center-based 
prospective study 
Coronary heart 
disease (462) 
<1 egg/week*, 1.19 (0.86 to 1.64); 1-2 eggs/week, 
1.00 (0.77 to 1.30); 3-4 eggs/week, 1.00 (0.79 to 
1.26); almost daily, 1.0 (reference)  
Age; sex; body mass index; 
hypertension; diabetes; use of 
cholesterol lowering drugs; smoking; 
alcohol drinking; whether participants 
intended to avoid cholesterol rich diets; 
consumption frequencies of meat, fish, 
vegetables, and fruits; and cohort 
effects 
Quershi, 
2007 
NHANES-I Coronary artery 
disease (1584) 
Coronary artery disease: <1 egg/week, 1.0 (reference); 
1-6, 1.0 (0.9 to 1.1); >6, 1.1 (0.9 to 1.3)  
Age, sex, race or ethnicity, systolic 
blood pressure, diabetes mellitus, 
serum cholesterol, smoking, body mass 
index, and educational status 
 stroke (655) Stroke: <1 egg/week, 1.0 (reference); 1-6, 0.9 (0.7 to 
1.0); >6, 0.9 (0.7 to 1.1)  
!%#
 
Table 14 (Continued) 
Study Population Country sex Age at 
baseline 
# participants mean 
follow-
up 
Case 
ascertainment 
Djousse, 
2008 
Physician's 
Health Study I 
USA Male 40-85 21327 20 Confirmed by 
physicians or 
medical records  
Scrafford, 
2010 
NHANES III USA Male 17+ 6833 8.8 Not applicable  
Female 17+ 8113 8.9 Not applicable  
Sands, 2015 Health 
Professionals 
Follow-up 
Study 
USA Male 40-75 42,961 20.4 Self-reported 
diagnosis or 
confirmed by 
medical records or 
autopsy  
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Table 14 (Continued) 
Study Population Endpoints Relative risks Covariates in fully adjusted model 
Djousse, 
2008 
Physician's 
Health Study I 
Myocardial 
infarction (1550) 
Myocardial infarction: <1 egg/week, 1.0 
(reference); 1, 1.12 (0.96 to 1.31); 2-4, 1.16 (1.00 
to 1.36); 5-6, 1.18 (0.93 to 1.49); ≥7, 0.90 (0.72 to 
1.14)  
Age, body mass index, smoking, history of 
hypertension, vitamin intake, alcohol 
consumption, vegetable consumption, 
breakfast cereal, physical activity, treatment 
arm, atrial fibrillation, diabetes mellitus, 
hypercholesterolemia, and parental history of 
premature myocardial infarction  
stroke (1342) Stroke:<1egg/week,1.0(reference);1,0.96(0.82to 
1.13);2-4,1.06(0.91to1.24);5-6,1.13(0.89to1.42); 
≥7, 0.99 (0.80 to 1.23)  
Scrafford, 
2010 
NHANES III Coronary heart 
disease mortality 
(198) 
Coronary heart disease mortality: <1 egg/week, 
1.0 (reference); 1-6, 1.26 (0.79 to 2.00); >6, 1.13 
(0.61 to 2.11) 
Age, energy, marital status, educational 
status, race or ethnicity, smoking, body mass 
index, waist to hip ratio, diabetes, 
hypertension, and dietary variables  stroke mortality 
(63) 
Stroke mortality: <1 egg/week, 1.0 (reference); 1-
6, 1.00 (0.49 to 2.02); >6, 0.27 (0.10 to 0.73) 
Coronary heart 
disease mortality 
(168) 
Coronary heart disease mortality: <1 egg/week, 
1.0 (reference); 1-6, 1.12 (0.66 to 1.89); >6, 0.92 
(0.27 to 3.11)  
Age, energy, marital status, educational 
status, race or ethnicity, smoking, body mass 
index, waist to hip ratio, diabetes, 
hypertension, and dietary variables   stroke mortality 
(74) 
Stroke mortality: <1 egg/week, 1.0 (reference); 1-
6, 0.93 (0.46 to 1.90); >6, 1.03 (0.25 to 4.22) 
Sands, 2015 Health 
Professionals 
Follow-up Study 
Cardiovascular 
disease (4,270) 
<1 egg/month, 1.0 (reference); 1-
3/month,0.93(0.85, 1.01); 1/week, 0.91(0.84, 
0.99); 2-4/week, 0.93(0.85, 1.03); 5-6/week, 
0.86(0.71, 1.03); ≥1/day, 1.07(0.91, 1.25) 
age, smoking, BMI, physical activity, race, 
family history of CVD, high blood 
cholesterol at baseline, high blood pressure 
at baseline, statin use at baseline, alcohol 
intake, multivitamin use, calories, whole 
milk, bacon, other red and processed meat, 
refined grains, coffee 
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Table 14 (Continued) 
Study Population Country sex Age at 
baseline 
# participants mean 
follow-
up 
Case 
ascertainment 
 
Nurses' Health Study  USA Female 34-59 70,235 27.3 Self-reported 
diagnosis or 
confirmed by 
medical records 
or autopsy  
Nurses' Health Study II USA Female 25-42 91,032 19.6 Self-reported 
diagnosis or 
confirmed by 
medical records 
or autopsy  
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Table 14 (Continued) 
Study Population Endpoints Relative risks Covariates in fully adjusted 
model 
 
Nurses' Health Study  Cardiovascular 
disease (3,188) 
<1 egg/month, 1.0 (reference); 1-3/month, 1.03(0.91, 
1.17); 1/week, 0.96(0.86, 1.07); 2-4/week, 0.91(0.81, 
1.03); 5-6/week, 1.04(0.86, 1.27); ≥1/day, 1.15(0.95, 
1.40) 
age, smoking, BMI, physical 
activity, race, family history of 
CVD, high blood cholesterol at 
baseline, high blood pressure at 
baseline, statin use at baseline, 
postmenopausal hormone use, 
alcohol intake, multivitamin use, 
calories, whole milk, bacon, other 
red and processed meat, refined 
grains, coffee 
Nurses' Health Study II Cardiovascular 
disease (521) 
<1 egg/month, 1.0 (reference); 1-3/month, 0.92(0.76, 
1.11); 1/week,1.02(0.85, 1.22); 2-4/week,0.87(0.67, 
1.14); 5-6/week, 0.70(0.32, 1.52); ≥1/day, 0.83(0.33, 
2.07) 
age, smoking, BMI, physical 
activity, race, family history of 
CVD, high blood cholesterol at 
baseline, high blood pressure at 
baseline, statin use at baseline, 
postmenopausal hormone use, oral 
contraceptive use, alcohol intake, 
multivitamin use, calories, whole 
milk, bacon, other red and 
processed meat, refined grains, 
coffee 
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In the final analysis, four studies were included that examined both stroke and coronary 
heart disease risk, one study was included that examined only coronary heart disease risk and one 
study was included that examined only stroke risk (Table 14). We found a modestly increased 
risk of CVD with an increase in egg intake of 1 egg per day (HR: 1.05, 95% CI(1.01, 1.09)) using 
fixed effects meta-analysis, and no increased risk (HR: 1.01, 95% CI(0.94, 1.09)) using random 
effects (Figure 4). We found no association with eggs in the studies that examined incident CVD 
(HR: 1.02, 95% CI(0.98, 1.07)), but did find an increased risk with an increase of one egg per day 
in studies reporting on cardiovascular disease mortality (HR: 1.10, 95% CI(1.03, 1.17)) (Figure 
5). Among participants with type 2 diabetes we saw a significantly increased risk of CVD for an 
increase in one egg per day (HR: 1.24; 95% CI(1.12, 1.37)); However, this is based on only two 
studies due to missing information on case numbers and person-time in other publications.  
!∀∃!
 
Figure 4. Risk of Cardiovascular Disease with Consumption of 1 egg/day using fixed (A) and 
random (B) effects meta-analysis. Weights of each of the studies are represented by the size of 
the square. Black diamonds represent the individual study effects and black lines represent the 
95% confidence intervals. The overall effect estimate and 95% confidence interval is represented 
by the diamond and dotted line. 
 
A. 
B. 
NOTE: Weights are from random effects analysis
Overall  (I-squared = 39.6%, p = 0.052)
Scrafford et al Men 2010 (CHD)
AARP (CVD)
ID
Scrafford et al Women 2010 (CHD)
Scrafford et al Men 2011 (Stroke)
Study
Nakamura et al Men 2004 (Stroke)
Nakamura et al 2006 (CHD)
Djousse et al 2008 (Stroke)
Qureshi et al 2007 (CHD)
Nakamura et al Men 2004 (CHD)
Scrafford et al Women 2011 (Stroke)
Djousse et al 2008 (CHD)
Nakamura et al Women 2004 (Stroke)
Sands et al. 2015 (CVD)
Sauvaget et al 2003 (Stroke)
Qureshi et al 2007 (Stroke)
Nakamura et al Women 2004 (CHD)
1.01 (0.94, 1.09)
1.24 (0.80, 1.92)
1.13 (1.06, 1.21)
ES (95% CI)
0.85 (0.32, 2.27)
0.33 (0.14, 0.80)
0.80 (0.43, 1.49)
0.93 (0.59, 1.46)
0.99 (0.80, 1.23)
1.07 (0.93, 1.24)
1.93 (0.36, 10.30)
1.21 (0.42, 3.49)
0.90 (0.72, 1.13)
1.28 (0.82, 2.01)
1.04 (0.98, 1.10)
0.70 (0.51, 0.96)
0.93 (0.78, 1.11)
1.00 (0.52, 1.93)
100.00
2.60
21.51
Weight
0.56
0.69
%
1.35
2.47
8.17
13.16
0.19
0.48
7.45
2.45
22.50
4.67
10.53
1.22
  
1.0971 10.3
Overall  (I-squared = 39.6%, p = 0.052)
Nakamura et al Men 2004 (Stroke)
Sands et al. 2015 (CVD)
Scrafford et al Men 2010 (CHD)
Scrafford et al Women 2010 (CHD)
Nakamura et al Men 2004 (CHD)
Scrafford et al Men 2011 (Stroke)
Djousse et al 2008 (CHD)
Scrafford et al Women 2011 (Stroke)
Nakamura et al Women 2004 (CHD)
Qureshi et al 2007 (CHD)
Nakamura et al 2006 (CHD)
AARP (CVD)
Djousse et al 2008 (Stroke)
Sauvaget et al 2003 (Stroke)
Qureshi et al 2007 (Stroke)
Study
ID
Nakamura et al Women 2004 (Stroke)
1.05 (1.01, 1.09)
0.80 (0.43, 1.49)
1.04 (0.98, 1.10)
1.24 (0.80, 1.92)
0.85 (0.32, 2.27)
1.93 (0.36, 10.30)
0.33 (0.14, 0.80)
0.90 (0.72, 1.13)
1.21 (0.42, 3.49)
1.00 (0.52, 1.93)
1.07 (0.93, 1.24)
0.93 (0.59, 1.46)
1.13 (1.06, 1.21)
0.99 (0.80, 1.23)
0.70 (0.51, 0.96)
0.93 (0.78, 1.11)
ES (95% CI)
1.28 (0.82, 2.01)
100.00
0.38
44.15
0.77
0.15
0.05
0.19
2.79
0.13
0.34
7.12
0.73
33.04
3.18
1.52
4.73
%
Weight
0.72
  
1.0971 10.3
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Figure 5. Risk of Incident Cardiovascular Disease (A) and Cardiovascular Disease Mortality (B) 
with Consumption of 1 egg/day. Weights of each of the studies are represented by the size of the 
square. Black diamonds represent the individual study effects and black lines represent the 95% 
confidence intervals. The overall effect estimate and 95% confidence interval is represented by 
the diamond and dotted line. 
 
 
 
A. 
B. 
Overall  (I-squared = 0.0%, p = 0.660)
ID
Sands et al. 2015 (CVD)
Qureshi et al 2007 (Stroke)
Qureshi et al 2007 (CHD)
Study
Djousse et al 2008 (CHD)
Djousse et al 2008 (Stroke)
Nakamura et al 2006 (CHD)
1.02 (0.98, 1.07)
ES (95% CI)
1.04 (0.98, 1.10)
0.93 (0.78, 1.11)
1.07 (0.93, 1.24)
0.90 (0.72, 1.13)
0.99 (0.80, 1.23)
0.93 (0.59, 1.46)
100.00
Weight
70.41
7.55
11.35
%
4.45
5.08
1.16
  
1.593 1.69
Overall  (I-squared = 51.1%, p = 0.031)
Nakamura et al Women 2004 (Stroke)
ID
Scrafford et al Men 2011 (Stroke)
Study
Nakamura et al Men 2004 (Stroke)
Scrafford et al Women 2010 (CHD)
Sauvaget et al 2003 (Stroke)
AARP (CVD)
Nakamura et al Women 2004 (CHD)
Scrafford et al Women 2011 (Stroke)
Nakamura et al Men 2004 (CHD)
Scrafford et al Men 2010 (CHD)
1.10 (1.03, 1.17)
1.28 (0.82, 2.01)
ES (95% CI)
0.33 (0.14, 0.80)
0.80 (0.43, 1.49)
0.85 (0.32, 2.27)
0.70 (0.51, 0.96)
1.13 (1.06, 1.21)
1.00 (0.52, 1.93)
1.21 (0.42, 3.49)
1.93 (0.36, 10.30)
1.24 (0.80, 1.92)
100.00
1.94
Weight
0.51
%
1.02
0.41
4.08
88.56
0.92
0.35
0.14
2.07
  
1.0971 10.3
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DISCUSSION 
In this sample of 245,746 men and women in the NIH-AARP Diet and Health study, we 
observed a slight increased risk of CVD mortality associated with consumption of one egg or 
more per day intake after adjustment for confounders. Among participants with T2D at baseline, 
an increase in egg intake was significantly associated with an increased risk of CVD mortality.  
In the updated meta-analysis, there was a similarly modest increase in risk of CVD with 
increases in egg consumption of 1 egg per day using fixed effects meta-analysis but not with 
random-effects. Random-effects meta-analysis allows the true risk to vary between studies and 
tends to give more weight to smaller studies than fixed-effects meta-analysis. Although there is a 
moderate amount of heterogeneity between the studies included, it is not statistically significant 
(p=0.05); therefore, the fixed-effects may be more representative of the true association. In the 
meta-analysis, we also observed a significantly increased risk of CVD with egg consumption 
among those with T2D. 
Although we found a modestly significant association between an increase in 
consumption of 1 egg per day and risk of CVD in the AARP cohort, it is possible that some of 
this association may be the result of unmeasured confounding in participants at higher risk due to 
T2D. We saw an increased risk of CVD among participants reporting T2D at baseline; 
misclassification due to more undiagnosed or unreported T2D in the one egg per day group may 
be driving the association. Our findings of an increased risk of CVD among participants with 
T2D are consistent with the previously published meta-analysis which found an increased risk of 
CHD (HR: 1.54; 95% CI:1.14, 2.09) in the highest category of egg intake compared to the lowest 
among participants with T2D.
27
 It has been hypothesized that the increased levels of insulin 
resistance and changes in alipoprotein levels seen with T2D (specifically decreased 
apolipoprotein E and increased apolipoprotein CII) may lead to changes in lipoprotein transport 
and HDL metabolism that result in an increased risk of CVD.
53-56
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To date, no other studies have reported a significant interaction with race. In the current 
study, there were 93.1% non-Hispanic white, 3.0% non-Hispanic black, 1.6% Hispanic, 1.1% 
Asian, 0.1% pacific Islander and 0.2% American Indian participants. Those with the highest risk 
were non-Hispanic blacks, who had an increased risk of CVD mortality with an increase of one 
egg per day of (HR: 1.63, 95% CI: (1.22, 2.20)). More research is needed to confirm or refute this 
finding.  
In the past, limiting dietary cholesterol was recommended for the reduction of blood 
cholesterol levels; however, this hypothesized relationship has not been confirmed in the 
literature. Indeed, both the AHA/ACC 2013 guidelines and the 2015 Dietary Guidelines 
Committee Report do not include a recommended upper limit for dietary cholesterol due to the 
lack of a clear relationship between dietary and serum cholesterol
3, 46
. In 2007-2008, the average 
dietary cholesterol intake in US adults measured through NHANES was 298 mg/d, which 
corresponds to about 1.5 eggs if no other sources of dietary cholesterol are consumed
57
. Although 
eggs contain a large amount of dietary cholesterol, variation in their intake appears to have little 
effect on serum total or LDL cholesterol levels in people consuming moderate amounts of dietary 
cholesterol
26
. Intake of saturated fat is a much stronger driver of serum LDL
58
. In addition to 
dietary cholesterol, eggs contain a variety of nutrients beneficial to health such as polyunsaturated 
fats and B-vitamins
4
.  
The AARP cohort has several strengths. The large sample size and diverse population 
allows for robust results and the ability to examine risk status stratified by race, T2D, and other 
factors. In addition, we were able to better control for confounding by dietary factors commonly 
consumed with eggs, such as bacon, red and processed meat, potatoes, refined carbohydrates, 
coffee, whole milk, sugar sweetened beverages and juice, than in previous analyses.  In this and 
many western populations, those who consume more eggs tend to have a host of other 
unfavorable risk factors; thus, inadequate control for confounding would tend to lead to 
exaggerated risk associated with egg intake. 
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The current analyses also have several limitations. First, the population includes only 
those older than 50; therefore, results may not be generalizable to younger populations. However, 
this may also be viewed as a strength because the population is at higher risk for CVD, allowing 
for greater power to detect an association than previous publications due to a higher number of 
cases. Second, because CVD incidence was not collected during follow-up, we were only able to 
examine the risk of CVD mortality. Third, there is some degree of misclassification due to 
random measurement error in the measurement of diet as a result of using the FFQ. The manner 
in which egg intake was assessed on the FFQ, which asks for usual type of egg intake, could also 
introduce additional random measurement error. The lack of dietary collection after baseline may 
also increase the possibility of misclassification if there are changes in diet after baseline that are 
not captured. This misclassification could lead to a decreased association between egg intake and 
the risk of CVD. In addition, because diagnosis of T2D was only reported at baseline, our 
analyses may include some unreported cases of T2D. We cannot eliminate the possibility of 
residual or unmeasured confounding in our analyses despite having adjusted for many important 
covariates.  
Higher egg intake was associated with a modestly increased risk of CVD mortality after 
adjustment for diet and lifestyle factors in the AARP Study. A similar association was seen for 
the risk of CVD in the meta-analysis of current prospective cohort studies. There was a 
significant positive association between egg intake and risk of CVD among participants with T2D 
and in non-white participants. Taken together, these results suggest that eggs are associated with 
little increased overall risk of cardiovascular mortality, but specific population subgroups – such 
as those with T2D may consider limiting egg intake.   
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ABSTRACT 
Background 
In the current literature, there is no clear consensus on whether egg consumption is associated 
with the risk of type 2 diabetes (T2D).   
Objective 
The goal of this study is to determine the association between egg intake and risk of T2D in three 
large prospective cohorts, and to perform a meta-analysis of prospective cohort studies.  
Design  
The final study population includes 42,479 men from the Health Professionals Follow-up Study 
(HPFS: 1986-2010), 69,480 women from the Nurses’ Health Study (NHS: 1980-2010) and 90,905 
women from the Nurses’ Health Study II (NHSII: 1991-2011). Participants were excluded if they reported 
cancer, cardiovascular disease (CVD) or T2D at baseline. Egg intake was assessed via a validated food 
frequency questionnaire every four years. Incident T2D was self-reported and confirmed through a 
validated supplemental questionnaire. We used Cox proportional hazard models to estimate relative risks 
(HR) and 95% confidence intervals (CI). Final multivariate models were adjusted for age, lifestyle and 
dietary factors. We also meta-analyzed these cohorts with previously published prospective cohorts.  
Results 
There were 16,570 incident cases of T2D in NHS, NHSII and HPFS. After multivariate 
adjustment, hazard ratios (95% confidence interval) by categories of egg intakes were: (HR(95% CI) by 
category: <1/month: 1(reference); 1-3/month: 1.02(0.96, 1.08); 1/week: 1.02(0.96, 1.08); 2-4/week: 
1.08(1.01, 1.15); 5-6/week: 1.18(1.06, 1.32); 1+/day: 1.03(0.92, 1.16) (p-trend=0.03). Using a continuous 
variable for egg intake, an increase of one egg per day was associated with an increased risk of T2D of 
(HR: 1.09, 95% CI: (1.01, 1.18)). In substitution analysis models, replacing eggs with legumes, low-fat 
dairy, nuts and whole grains was associated with lower risk of T2D by 9-18%, while replacing eggs with 
red and processed meats was associated with increased risk by 9%. In the meta-analysis of 9 prospective 
cohort studies (348,965 participants and 23,823 incident cases), we found a significantly increased risk of 
!∋∀!
T2D with an increase in egg consumption of 1 egg/day (HR: 1.13, 95% CI: (1.07, 1.19)) using fixed 
effects. However, this increased risk was no longer present when random effects were used (HR: 1.04, 
95% CI: (0.88, 1.23) (p-heterogeneity<0.001).  
Conclusions 
After controlling for lifestyle and dietary factors, higher egg intake (up to one egg per day) was 
associated with a small increased risk of incident T2D our cohorts. We found a similar increase in risk of 
T2D in an updated meta-analysis using fixed effects, but not when using random effects.  Replacing eggs 
with legumes, low-fat dairy, nuts and whole grains was associated with a decreased risk of T2D; however, 
replacing eggs with red and processed meat was associated with an increased risk of T2D.  
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INTRODUCTION 
In the US, it is estimated that there are over 25.6 million adults living with Type 2 Diabetes 
(T2D) 
24
. Lifestyle factors including overweight and obesity, physical activity, smoking status, alcohol 
consumption and diet play an important role in the development of T2D 
1, 2
. Consumption of 
polyunsaturated fatty acids may reduce risk of T2D, while saturated and trans fats may increase risk 
5
.  
Several studies have focused on the relationship between egg consumption, or dietary cholesterol 
and risk of T2D, but the results have been inconsistent. Djousse et al. found that in the Women’s Health 
and Physician’s Health cohort studies, egg intakes of ≥7 times per week was associated with increased 
risk of T2D 
59
, but this relationship was not significant in other cohort studies 
16, 17, 19-21, 60
. Two meta-
analyses reported a significant positive association between egg intake and T2D risk (14) 
61
. However, 
one of the meta-analyses also included case-control studies (potentially prone to recall bias) and two 
recently published studies have not been included in either meta-analysis 
19, 21
.  
The current study examines the association between egg consumption and risk of T2D in three 
large ongoing cohort studies: The Nurses’ Health Study (NHS), the Nurses’ Health Study II (NHS II), and 
the Health Professionals’ Follow-up Study (HPFS). Of the previously published studies, few have been 
able to adjust sufficiently for confounding by dietary variables. We also conducted an updated meta-
analysis of our results from these three cohorts as well as six previously published prospective cohort 
studies.  
 
METHODS 
NHS began in 1976 with 121,701 female registered nurses between the ages of 30-55. NHSII 
began in 1989 with 116,430 female registered nurses between the ages of 25-44. HPFS began in 1986 
with 51,529 male health professionals between the ages of 40-75. Self-administered validated 
questionnaires with information on disease diagnoses, health and lifestyle were completed every two 
years. Diet was measured through validated semi-quantitative food frequency questionnaires (FFQ) every 
4 years beginning in 1980 for NHSI, 1991 for NHSII and 1986 for HPFS 
28-30
. Follow-up rates were over 
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90%. Exclusion criteria included diagnosis with cancer, cardiovascular disease or T2D prior to baseline. 
Participants were also excluded if they were missing egg intake or total calories at baseline and if they 
reported unrealistic intake on the FFQ (>70 items blank, <500 or >3500 kcals/day for women and <800 or 
>4200 kcals/day for men). After exclusions, 69,383 participants in NHS, 90,903 participants in NHSII 
and 42,465 participants in HPFS were included in the analyses. The Institutional Review Board of the 
Brigham and Women’s Hospital in Boston approved all study protocols.  
 
Assessment of Egg Intake 
Dietary information was collected through a semi-quantitative FFQ with 61 items in 1980 and 
131 items beginning in 1984. The FFQ was administered every 4 years beginning in 1990 for NHS, 1991 
for NHSII and 1986 for HPFS. Each cycle, participants were asked how often on average they consumed 
eggs in the past year. Responses could range from never to six or more times per day. FFQ’s were 
validated against 7 day weighed food records in 127 men 
33
 and 173 women 
32
. Pearson correlation 
coefficients corrected for within-person variation for the FFQ and 7 day weighed record ranged from 0.17 
for spinach to 0.94 for yogurt and beer 
32
. The de-attenuated correlation for egg intake was 0.77 in women 
and 0.80 in men 
32, 33
. For the primary analysis, egg intake was divided into the following six categories: 
0-1 per month, 2-3 per month, 1 per week, 2-4 per week, 5-6 per week and ≥1 per day. In secondary 
analysis an additional category of ≥2 per day was added.  
 
Assessment of T2D 
Self-report of T2D diagnosis was collected via questionnaires every two years. Diagnoses were 
confirmed using a supplemental questionnaire, which asked about symptoms, medication use and 
diagnostic tests. This supplemental questionnaire was validated with 62 cases in NHS and 59 cases in 
HPFS. Of these self-reported T2D diagnoses, endocrinologists blinded to risk factor status confirmed 
T2D from review of medical records in 98% of NHS cases and 97% of HPFS cases 
62, 63
. Diabetes was 
defined as one or more classic symptoms (excessive thirst, polyuria, weight loss, hunger, pruritus, or 
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coma) plus the NDDG cut-points of fasting plasma glucose ≥140mg/dL or random plasma glucose 
≥200mg/dL until 1997 and the ADA cut-points of fasting plasma glucose ≥126mg/dL or random plasma 
glucose ≥200mg/dL after 1997; or at least two elevated plasma glucose levels on two occasions in the 
absence of symptoms; or treatment with hypoglycemic medication 
64
. We included confirmed cases only. 
After report of death, the date of death was confirmed from medical records, the National Death Index, 
tumor registries and death certificates. 
 
Statistical Methods 
Participants returned the first dietary questionnaire in 1980 in NHS, 1991 in NHSII and 1986 in 
HPFS. Follow up began with the return of the first questionnaire and ended with diagnosis with T2D, 
death, lost to follow-up, or the return of the last questionnaire prior to June 30
th
, 2010 in NHS, June 30
th
 
2011 in NHSII and January 31
st
 2010 in HPFS. Cox proportional hazards models were used to calculate 
hazard ratios and 95% confidence intervals for incident T2D. We confirmed the assumption of 
proportional hazards with a likelihood ratio test based on inclusion of a time to event interaction term. To 
represent long-term diet and reduce within-person variation a cumulative average update method was 
used for egg intake and other dietary variables 
37
. Whole eggs did not include eggs prepared within mixed 
dishes such as baked goods. A trend across categories of egg consumption was calculated from the 
median of each category of egg intake 
38
.  
Multivariate models included adjustment for age, cohort, two year time intervals, sex, 
race/ethnicity, BMI, smoking status, physical activity, family history of T2D, diagnosis with hypertension 
or hypercholesterolemia at baseline, alcohol consumption, multivitamin use, postmenopausal status, use 
of postmenopausal hormones, use of oral contraceptives, total energy intake, and foods associated with 
egg intake including: bacon, red meat, other processed meat, whole milk, refined carbohydrates, potatoes, 
coffee, juice and sugar sweetened beverages.  Western dietary pattern score was also considered as a 
covariate but ultimately not included in the final model due to overlap with the individual foods. As with 
egg intake, a cumulative average update was used for all dietary variables. Interactions were tested using 
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likelihood ratio tests, and stratified analyses were performed for updated age, BMI, physical activity, 
hypertension, high blood cholesterol, smoking and family history of T2D.  
In sensitivity analyses, the joint effect of eggs and BMI on incident T2D was calculated using 
three categories of BMI (<25, 25-29.9, ≥30) and four categories of egg intake (<3/month, 1/week, 2-
4/week, ≥5/week). P-values for interactions of the joint effect of eggs and BMI were determined from 
likelihood ratio tests. We determined the risk of incident T2D in seven categories of egg intake (including 
2 or more eggs per day) and in overall egg intake (including eggs from mixed foods). To determine the 
best model to minimize measurement error, and also account for the latency period of disease, we also 
repeated analyses with simple update of diet and baseline diet rather than cumulative average intake. In 
addition, the change in egg intake after diagnosis with hypertension, high blood cholesterol, angina, 
CABG or beginning statin use was examined, and analyses were conducted where we stopped updating 
diet after diagnosis with hypertension, high blood cholesterol or beginning statin use to explore the 
possibility of confounding due to diagnosis with an intermediate endpoint. We also examined the effects 
of substituting eggs by 1 serving of other common food groups on risk of T2D. We included continuous 
variables for both eggs and the other food in the model along with other non-dietary confounders. We 
used the differences between the beta-coefficients, variance and the covariance of eggs and the other food 
to calculate HR’s and 95% CI’s for incident T2D. All p-values were two-sided and statistical analyses 
were performed using SAS v.9.3 (SAS Institute, Inc., Cary, NC). 
We conducted a meta-analysis based on the current study and previous literature. We used the 
key words: “Diabetes Mellitus"[MeSH],  “Diabetes Mellitus, Type 2"[MeSH], diabetes, T2D, insulin 
resistance and egg to search PubMed and Embase through June, 2015.  We calculated Relative risks for 
one egg per day using the trend for log relative risks, which accounted for correlated estimates
38, 52
. To 
determine dose of egg consumption we used the median of each egg intake category if available, or the 
midpoint between the upper and lower bound. For studies that did not publish person-years for each 
category of egg intake, we imputed person years based on available data. Fixed effects were used when 
heterogeneity was low, otherwise random effects were used. Heterogeneity was assessed using the 
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Cochran Q test and I
2
 statistic. Statistical analysis for the meta-analysis was performed using Stata v.12 
(StataCorp, College Station, TX).   
 
RESULTS 
During follow-up, we recorded 7,728 cases of T2D after 28 years of follow-up in NHS, 5,345 
cases after 20 years of follow-up in NHSII and 3,497 cases after 22 years of follow-up in HPFS. We 
found that in 1994 for NHS and HPFS and 1995 for NHSII, higher egg intake was associated with less 
reported high blood cholesterol and statin use, and higher intakes of total calories, red meat, processed 
meat, bacon, potatoes, whole milk, coffee and dietary cholesterol. (Table 15). 
In analyses adjusted for age alone, higher egg intake was associated with increased risk of T2D in 
all categories of egg intake (HR(95% CI) by category: <1/month (Ref); 1-3/month: 1.12(1.06, 1.20); 
1/week: 1.28( 1.21, 1.36); 2-4/week: 1.54( 1.45, 1.64); 5-6/week: 1.79( 1.61, 2.00); ≥1/day: 1.58(1.42, 
1.77), p-trend<0.001) (Table 16). After multivariate adjustment, results were largely attenuated (HR(95% 
CI) by category: <1/month (Ref); 1-3/month: 1.02(0.96, 1.08); 1/week: 1.02(0.96, 1.08); 2-4/week: 
1.08(1.01, 1.15); 5-6/week: 1.18(1.06, 1.32); ≥1/day: 1.03(0.92, 1.16), p-trend=0.03) (Table 16). Each 
increase of one egg per day was associated with an increased risk of T2D of (HR: 1.09, 95% CI: (1.01, 
1.18)) (Table 16). We found no significant interactions for age, BMI, physical activity, smoking or family 
history of T2D (Table 17). Participants who did not have hypertension during follow-up had a somewhat 
higher risk of T2D with increasing egg intake compared to participants who did not currently have 
hypertension (p-interaction<0.001). Participants who did not currently have high blood cholesterol had a 
trend towards increased risk of T2D with increasing egg intake while participants reporting high blood 
cholesterol during follow-up did not (p-interaction<0.001). Similarly, patients who were not taking statins 
had a trend towards increased risk of T2D with increasing egg intake, but this was not found among those 
who reported taking statins (p-interaction=0.001). These results were similar in each of the three cohorts. 
 
 
!∀#!
Table 15. Age-Standardized Characteristics of Participants in NHSI, NHSII and HPFS in 1994 
*
Body mass index calculated as weight in kilograms divided by height in meters squared 
Abbreviations: Number (No), Year (y), week (wk), servings (serv), ounces (oz), grams (g) 
 Whole Egg Intake 
 Nurses’ Health Study I  Nurses’ Health Study II  Health Professionals Follow-Up Study 
Characteristics 0/month 2-4/week ≥1/day  0/month 2-4/week ≥1/day  0/month 2-4/week ≥1/day 
Participants, No 4,013 15,054 1,251  16,427 11,672 373  6,579 8,113 1,239 
Age, mean, y 60.9 59.7 59.5  40.3 40.6 41.1  60.2 61.5 61.8 
Body Mass Index
*
, mean, kg/m
2
 25.4 26.8 27.1  24.9 26.6 27.4  25.3 26.4 26.1 
Physical Activity, mean, Met h/wk 20.4 19.6 19.6  24.6 18.9 21.9  38.6 35.0 36.9 
White, % 98 98 98  96 96 94  95 95 95 
Smoking Status            
   Never smoker, % 40 47 42  65 67 66  54 48 43 
   Past smoker, % 44 40 43  25 22 21  42 43 43 
   Current smoker, % 17 12 15  10 11 13  4 9 14 
Postmenopausal,  % 90 89 90  8 7 8     
Current menopausal hormone use, % 36 39 39  6 5 4     
Current oral contraceptive use, %     9 7 8     
Family history of diabetes mellitus, % 28 28 32  16 17 19  15 14 13 
High blood pressure, % 40 40 42  9 10 16  36 33 29 
High blood cholesterol, % 50 45 44  20 16 15  49 33 29 
Current multivitamin use, % 43 46 48  59 61 63  64 59 60 
Current statin use, % 23 17 16  4 2 3  13 4 3 
Dietary intake, mean            
   Total Energy, kcal/d 1,459 1,789 1,877  1,583 2,089 2,203  1,792 2,173 2,348 
   Alcohol, g/d 5.9 6.5 6.7  3.1 3.5 2.9  9.3 12.2 11.7 
   Bacon, servings/d 0.0 0.1 0.2  0.0 0.1 0.2  0.0 0.2 0.3 
   Red meat, servings/d 0.9 1.0 1.0  0.5 0.9 0.9  0.5 0.9 1.1 
   Other processed meat, servings/d 0.1 0.2 0.3  0.1 0.2 0.3  0.1 0.3 0.3 
   Refined carbohydrates, servings/d 1.0 1.3 1.2  0.8 1.2 1.4  0.8 1.1 1.3 
   Potatoes, servings/d 0.7 0.8 0.8  0.4 0.6 0.6  0.5 0.6 0.7 
   Whole milk, servings/d 0.1 0.2 0.3  0.0 0.1 0.2  0.0 0.2 0.3 
   Coffee, servings/d 2.2 2.4 2.5  1.5 1.6 1.6  1.6 2.1 2.4 
   Juice, servings/d 0.5 0.5 0.5  0.6 0.8 0.8  0.8 0.8 0.8 
   Sugar-sweetened beverages, servings /d 0.3 0.3 0.3  0.4 0.6 0.6  0.3 0.4 0.4 
   Dietary cholesterol, mg/d 186 365 638  173 329 534  191 354 611 
!∀∃!
Table 16. Risk of Incident Type 2 Diabetes According to Categories of Whole Egg Consumption in NHSI, NHSII and HPFS 
 Frequency of Consumption Categories 
p-value 
for trend
* 
HR (95% CI) for 
a 1 serving per 
day increase 
 <1/month 1-3/month 1/week 2-4/week 5-6/week ≥1/day 
Nurses’ Health I Study 
Cases/ Person years, No. 403/101,591 943/239,584 3,529/801,118 2,359/557,457 246/58,218 248/60,136   
Age adjusted model 1 1 0.99 (0.88, 1.12) 1.07 (0.96, 1.18) 1.31 (1.17, 1.45) 1.51 (1.29, 1.78) 1.41 (1.20, 1.66) <0.001 1.55 (1.40, 1.72) 
Multivariable model 2
†
 1 1.01 (0.90, 1.14) 0.98 (0.89, 1.09) 1.11 (1.00, 1.24) 1.26 (1.07, 1.48) 1.09 (0.92, 1.28) 0.001 1.19 (1.07, 1.25) 
Multivariable model 3
c
 1 1.00 (0.88, 1.12) 0.94 (0.84, 1.05) 1.04 (0.93, 1.16) 1.15 (0.98, 1.36) 1.03 (0.87, 1.21) 0.07 1.11 (0.99, 1.24) 
         
Nurses’ Health II Study 
Cases/ Person years, No. 721/314,611 1,559/620,831 2,148/637,282 804/258,040 71/16,852 42/10,009   
Age adjusted model 1 1 1.16 (1.06, 1.27) 1.40 (1.29, 1.53) 1.74 (1.57, 1.93) 2.25 (1.76, 2.88) 2.19 (1.60, 2.99) <0.001 2.86 (2.44, 3.34) 
Multivariable model 2
†
 1 1.04 (0.95, 1.13) 1.14 (1.04, 1.24) 1.21 (1.09, 1.35) 1.35 (1.05, 1.73) 1.20 (0.87, 1.64) <0.001 1.45 (1.23, 1.71) 
Multivariable model 3
‡
 1 1.01 (0.92, 1.10) 1.07 (0.97, 1.17) 1.09 (0.98, 1.22) 1.19 (0.92, 1.54) 1.01 (0.73, 1.40) 0.07 1.19 (0.99, 1.42) 
         
Health Professionals Follow-up Study 
Cases/ Person years, No. 415/132,295 682/190,945 1,246/288,898 899/219,283 120/27,960 135/35,481   
Age adjusted model 1 1 1.19 (1.05, 1.35) 1.34 (1.20, 1.50) 1.53 (1.35, 1.72) 1.71 (1.39, 2.10) 1.39 (1.14, 1.70) <0.001 1.36 (1.21, 1.53) 
Multivariable model 2
†
 1 1.12 (0.99, 1.27) 1.18 (1.05, 1.32) 1.28 (1.14, 1.45) 1.40 (1.13, 1.73) 1.18 (0.96, 1.44) 0.006 1.18 (1.05, 1.33) 
Multivariable model 3
‡
 1 1.07 (0.94, 1.21) 1.07 (0.94, 1.20) 1.11 (0.97, 1.27) 1.19 (0.95, 1.49) 1.02 (0.82, 1.26) 0.67 1.03 (0.90, 1.18) 
         
Pooled Results
 
Cases/ Person years, No. 1,539/548,497 3,184/1,051,360 6,923/1,727,298 4,062/1,034,780 437/103,030 425/105,626   
Age adjusted model 1 1 1.12 (1.06, 1.20) 1.28 (1.21, 1.36) 1.54 (1.45, 1.64) 1.79 (1.61, 2.00) 1.58 (1.42, 1.77) <0.001 1.66 (1.55, 1.77) 
Multivariable model 2
† 
1 1.06 (0.99, 1.12) 1.10 (1.04, 1.17) 1.21 (1.14, 1.29) 1.36 (1.22, 1.52) 1.16 (1.04, 1.30) <0.001 1.24 (1.16, 1.33) 
Multivariable model 3
‡ 
1 1.02 (0.96, 1.08) 1.02 (0.96, 1.08) 1.08 (1.01, 1.15) 1.18 (1.06, 1.32) 1.03 (0.92, 1.16) 0.03 1.09 (1.01, 1.18) 
*
P-values for trend based on continuous egg variable derived from the median egg intake in each category of consumption 
†
Multivariable model 2 includes: age (months), sex (male, female), smoking status (never, former, current), BMI (kg/m
2
: categorical <21, 21-<23, 23-<25, 25-
<27, 27-<30, 30-<35, 35-<40, 40+), physical activity (MET-hours/week: categorical <3, 3-<9, 9-<18, 18-<27, 27+), oral contraceptive use (never, former, 
current), post-menopausal hormone use (premenopausal, never, former, current), race (Caucasian, other), family history of T2D (yes, no), high blood pressure at 
baseline (yes, no), high blood cholesterol at baseline (yes, no), alcohol intake (servings/d), multivitamin use (yes, no) 
‡
Multivariable model 3 includes: 
 
model 2 with total calories (per day: quintiles), whole milk (categorical: servings/d), bacon (categorical: servings/d), red meat 
(categorical: servings/d), other processed meat (categorical: servings/d), refined carbohydrates (categorical: servings/d), potatoes (categorical: servings/d), coffee 
(categorical: servings/d), juice (categorical: servings/d), sugar-sweetened beverages (categorical: servings/d) 
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Table 17. Stratified Analysis of Risk of Incident Type 2 Diabetes According to Categories of Whole Egg Consumption in NHSI, NHSII and 
HPFS: Pooled Results
*
 
Variable 
Cases/Person 
Years 
Frequency of Consumption Categories p-value 
for 
trend
† 
<1/month 1-3/month 1/week 2-4/week 5-6/week ≥1/day  
Age < 65
 
11,584/3.686,096 1 1.03 (0.96, 1.11) 1.04 (0.97, 1.11) 1.13 (1.05, 1.22) 1.23 (1.07, 1.40) 1.07 (0.93, 1.22)  0.009 
Age ≥ 65 4,986/884,494 1 0.98 (0.86, 1.10) 0.96 (0.85, 1.07) 0.99 (0.87, 1.11) 1.08 (0.87, 1.33) 0.94 (0.77, 1.16)  0.92 
   
BMI < 25 2,480/2,410,378 1 0.95 (0.81, 1.11) 0.93 (0.80, 1.07) 1.07 (0.91, 1.25) 1.09 (0.81, 1.47) 1.00 (0.74, 1.33)  0.30 
BMI ≥ 25 14,090/2,160,212 1 1.03 (0.97, 1.11) 1.04 (0.98, 1.11) 1.09 (1.02, 1.18) 1.21 (1.07, 1.37) 1.03 (0.91, 1.17)  0.05 
          
≥ 10 MET/wk PA 9,374/1,995,971 1 1.02 (0.94, 1.11) 0.99 (0.92, 1.08) 1.08 (0.99, 1.18) 1.21 (1.04, 1.41) 0.96 (0.83, 1.13)  0.25 
< 10 MET/wk PA 7,196/2,574,619 1 1.02 (0.93, 1.12) 1.04 (0.95, 1.13) 1.07 (0.97, 1.18) 1.18 (0.99, 1.41) 1.15 (0.97, 1.37)  0.03 
   
Non smoker 8,434/2,624,017 1 1.01 (0.93, 1.10) 1.04 (0.96, 1.13) 1.11 (1.02, 1.22) 1.29 (1.10, 1.51) 1.09 (0.91, 1.29)  0.005 
Ever smoker 8136/1,946,573 1 1.03 (0.94, 1.13) 0.98 (0.90, 1.06) 1.04 (0.95, 1.15) 1.11 (0.94, 1.30) 1.00 (0.85, 1.17)  0.58 
   
No hypertension 5,974/3,255,712 1 0.93 (0.84, 1.03) 0.98 (0.89, 1.08) 1.07 (0.96, 1.19) 1.17 (0.98, 1.40) 1.10 (0.92, 1.32)  0.004 
Hypertension 10,596/1,314,878 1 1.08 (1.00, 1.17) 1.05 (0.97, 1.13) 1.12 (1.03, 1.22) 1.22 (1.05, 1.42) 1.02 (0.88, 1.19)  0.20 
          
Normal blood cholesterol 7,136/3,081,197 1 0.98 (0.88, 1.08) 1.04 (0.94, 1.14) 1.15 (1.04, 1.28) 1.21 (1.03, 1.42) 1.07 (0.90, 1.26)  0.006 
High blood cholesterol 9,434/1,489,393 1 1.05 (0.97, 1.14) 1.01 (0.94, 1.09) 1.05 (0.96, 1.14) 1.15 (0.97, 1.36) 1.02 (0.86, 1.21)  0.55 
          
No statin use 13,068/4,179,438 1 1.02 (0.95, 1.10) 1.04 (0.97, 1.11) 1.14 (1.06, 1.22) 1.25 (1.11, 1.42) 1.10 (0.97, 1.24)  <0.001 
Statin use 3,502/391,152 1 1.05 (0.92, 1.19) 1.01 (0.90, 1.14) 0.97 (0.84, 1.12) 0.97 (0.70, 1.34) 0.86 (0.62, 1.20)  0.20 
          
No family history 8,681/3,311,468 1 1.03 (0.95, 1.13) 1.05 (0.97, 1.14) 1.09 (1.00, 1.20) 1.17 (1.00, 1.37) 1.12 (0.96, 1.30)  0.03 
Family history of T2D 7,889/1,259,122 1 1.00 (0.92, 1.10) 0.99 (0.91, 1.08) 1.09 (0.99, 1.20) 1.18 (1.00, 1.40) 0.95 (0.79, 1.13)  0.27 
*
All results use multivariable model 3 and include: age (months), sex (male, female), smoking status (never, former, current), BMI (kg/m
2
: categorical <21, 21-
<23, 23-<25, 25-<27, 27-<30, 30-<35, 35-<40, 40+), physical activity (MET-hours/week: categorical <3, 3-<9, 9-<18, 18-<27, 27+), oral contraceptive use 
(never, former, current), post-menopausal hormone use (premenopausal, never, former, current), race (Caucasian, other), family history of T2D (yes, no), high 
blood pressure at baseline (yes, no), high blood cholesterol at baseline (yes, no), statin use at baseline (yes, no: only available for HPFS), alcohol intake 
(servings/d), multivitamin use (yes, no), total calories (per day: quintiles), whole milk (categorical: servings/d), bacon (categorical: servings/d), red meat 
(categorical: servings/d), other processed meat (categorical: servings/d), refined carbohydrates (categorical: servings/d), potatoes (categorical: servings/d), coffee 
(categorical: servings/d), juice (categorical: servings/d), sugar-sweetened beverages (categorical: servings/d) 
†
P-values for trend based on continuous egg variable derived from the median egg intake in each category of consumption 
‡
P-values for interaction calculated using the likelihood ratio test 
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Table 17 (Continued) 
Variable 
Cases/Person 
Years 
p-value 
for 
trend
† 
HR (95% CI) 
for a 1 serving 
per day 
increase 
p-int.
 ‡ 
Age < 65
 
11,584/3.686,096  0.009 1.13 (1.03, 1.24) 0.11 
Age ≥ 65 4,986/884,494  0.92 1.01 (0.88, 1.16)  
   
BMI < 25 2,480/2,410,378  0.30 1.11 (0.91, 1.35) 0.61 
BMI ≥ 25 14,090/2,160,212  0.05 1.09 (1.00, 1.18)  
      
≥ 10 MET/wk PA 9,374/1,995,971  0.25 1.06 (0.96, 1.18) 0.16 
< 10 MET/wk PA 7,196/2,574,619  0.03 1.14 (1.01, 1.28)  
   
Non smoker 8,434/2,624,017  0.005 1.18 (1.05, 1.31) 0.50 
Ever smoker 8136/1,946,573  0.58 1.03 (0.93, 1.15)  
   
No hypertension 5,974/3,255,712  0.004 1.20 (1.06, 1.35) <0.001 
Hypertension 10,596/1,314,878  0.20 1.07 (0.97, 1.18)  
      
Normal blood cholesterol 7,136/3,081,197  0.006 1.16 (1.04, 1.29) <0.001 
High blood cholesterol 9,434/1,489,393  0.55 1.03 (0.93, 1.16)  
      
No statin use 13,068/4,179,438  <0.001 1.16 (1.07, 1.26) 0.001 
Statin use 3,502/391,152  0.20 0.87 (0.71, 1.07)  
      
No family history 8,681/3,311,468  0.03 1.12 (1.01, 1.24) 0.09 
Family history of T2D 7,889/1,259,122  0.27 1.07 (0.95, 1.20)  
*
All results use multivariable model 3 and include: age (months), sex (male, female), smoking status (never, former, current), BMI (kg/m
2
: categorical <21, 21-
<23, 23-<25, 25-<27, 27-<30, 30-<35, 35-<40, 40+), physical activity (MET-hours/week: categorical <3, 3-<9, 9-<18, 18-<27, 27+), oral contraceptive use 
(never, former, current), post-menopausal hormone use (premenopausal, never, former, current), race (Caucasian, other), family history of T2D (yes, no), high 
blood pressure at baseline (yes, no), high blood cholesterol at baseline (yes, no), statin use at baseline (yes, no: only available for HPFS), alcohol intake 
(servings/d), multivitamin use (yes, no), total calories (per day: quintiles), whole milk (categorical: servings/d), bacon (categorical: servings/d), red meat 
(categorical: servings/d), other processed meat (categorical: servings/d), refined carbohydrates (categorical: servings/d), potatoes (categorical: servings/d), coffee 
(categorical: servings/d), juice (categorical: servings/d), sugar-sweetened beverages (categorical: servings/d) 
†
P-values for trend based on continuous egg variable derived from the median egg intake in each category of consumption 
‡
P-values for interaction calculated using the likelihood ratio test 
!∀#!
When we examined the effect of substituting eggs by other food groups on the risk of T2D we 
found that substituting eggs with legumes (HR: 0.91, 95% CI: (0.84, 0.98)), low fat dairy (HR: 0.88, 95% 
CI: (0.83, 0.93)), nuts (HR: 0.86, 95% CI: (0.80, 0.92)) and whole grains (HR: 0.82, 95% CI: (0.77, 0.87)) 
significantly decreased the risk of T2D. Substituting eggs with red and processed meats increased the risk 
of T2D (HR: 1.09, 95% CI: (1.02, 1.16)) (Figure 6).  
 
!
Figure 6. Hazard ratios and 95% CI’s for incident T2D associated with replacement of eggs with other 
food groups. Adjusted for: age (months), sex (male, female), smoking status (never, former, current), 
BMI (kg/m
2
: categorical <23, 23-<25, 25-<27, 27-<30, 30-<35, 35-<40, 40+), physical activity (MET-
hours/week: categorical <3, 3-<9, 9-<18, 18-<27, 27+), oral contraceptive use (never, former, current), 
post-menopausal hormone use (premenopausal, never, former, current), race (Caucasian, other), family 
history of MI (yes, no), baseline high blood cholesterol (yes, no), baseline high blood pressure (yes, no) 
statin use (yes, no), Alcohol intake (servings/d), multivitamin use (yes, no), total calories (per day: 
quintiles) 
 
In sensitivity analyses, we examined the joint effect of eggs and BMI on risk of T2D. We found 
an overall higher risk across categories of BMI compared to categories of egg intake (p-value for 
interaction=0.08) (Figure 7, Table 18). When we examined the risk of incident T2D according to seven 
categories of intake, we found a risk of (HR: 1.07, 95% CI: (0.84, 1.37)) in participants consuming at 
least two eggs per day. This was similar to the category of one egg per day (HR: 1.02, 95% CI: (0.91, 
1.16)) (Table 19).  
!∀∃!
!
Figure 7. Risk of Incident Type 2 Diabetes According to Joint Effects of Egg Consumption and BMI. 
Adjusted for age (months), sex (male, female), smoking status (never, former, current), physical activity 
(MET-hours/week: categorical <3, 3-<9, 9-<18, 18-<27, 27+), oral contraceptive use (never, former, 
current), post-menopausal hormone use (premenopausal, never, former, current), race (Caucasian, other), 
family history of T2D (yes, no), high blood pressure at baseline (yes, no), high blood cholesterol at 
baseline (yes, no), statin use at baseline (yes, no: only available for HPFS), alcohol intake (servings/d), 
multivitamin use (yes, no), total calories (per day: quintiles), whole milk (categorical: servings/d), bacon 
(categorical: servings/d), red meat (categorical: servings/d), other processed meat (categorical: 
servings/d), refined carbohydrates (categorical: servings/d), potatoes (categorical: servings/d), coffee 
(categorical: servings/d), juice (categorical: servings/d), sugar-sweetened beverages (categorical: 
servings/d 
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Table 18.  Risk of Incident Type 2 Diabetes According to the Joint Effects of Egg Consumption and BMI
*
 
*
All results use multivariable model 3 and include: age (months), sex (male, female), smoking status (never, former, current), physical activity (MET-
hours/week: categorical <3, 3-<9, 9-<18, 18-<27, 27+), oral contraceptive use (never, former, current), post-menopausal hormone use (premenopausal, never, 
former, current), race (Caucasian, other), family history of T2D (yes, no), high blood pressure at baseline (yes, no), high blood cholesterol at baseline (yes, no), 
Alcohol intake (servings/d), multivitamin use (yes, no), total calories (per day: quintiles), whole milk (categorical: servings/d), bacon (categorical: servings/d), 
red meat (categorical: servings/d), other processed meat (categorical: servings/d), refined carbohydrates (categorical: servings/d), potatoes (categorical: 
servings/d), coffee (categorical: servings/d), juice (categorical: servings/d), sugar-sweetened beverages (categorical: servings/d) 
†
P-values for trend based on continuous egg variable derived from the median egg intake in each category of consumption 
 
 
Table 19. Risk of Incident Type 2 Diabetes According to Seven Categories of Egg Consumption
*
 
 Frequency of Consumption Categories  
p- 
trend
† 
HR (95% CI) for 
a 1 serving per 
day increase 
 <1/month 1-3/month 1/week 2-4/week 5-6/week 1/day ≥2/day 
Cases/Person-
years, No. 
1,539/548,497 3,184/1,051,360 6,923/1,727,298 4,062/1,034,780 437/103,030 353/86,612 72/19,015  
 
NHS 1 1.00 (0.88, 1.12) 0.94 (0.84, 1.05) 1.04 (0.93, 1.16) 1.15 (0.98, 1.36) 1.00 (0.84, 1.19) 1.23 (0.86, 1.75) 0.03 1.12 (1.01, 1.24) 
NHSII 1 1.01 (0.92, 1.10) 1.07 (0.97, 1.17) 1.09 (0.98, 1.22) 1.19 (0.92, 1.54) 1.08 (0.77, 1.51) 0.55 (0.17, 1.73) 0.18 1.12 (0.95, 1.31) 
HPFS 1 1.07 (0.94, 1.21) 1.07 (0.94, 1.20) 1.11 (0.97, 1.27) 1.19 (0.95, 1.49) 1.00 (0.79, 1.27) 1.07 (0.74, 1.55) 0.61 1.03 (0.91, 1.16) 
Pooled Results 1 1.02 (0.96, 1.08) 1.02 (0.96, 1.08) 1.08 (1.01, 1.15) 1.18 (1.06, 1.32) 1.02 (0.91, 1.16) 1.07 (0.84, 1.37) 0.03 1.08 (1.01, 1.16) 
*
All results are from Multivariable Model 3 and include: age (months), sex (male, female), smoking status (never, former, current), BMI (kg/m
2
: categorical <21, 
21-<23, 23-<25, 25-<27, 27-<30, 30-<35, 35-<40, 40+), physical activity (MET-hours/week: categorical <3, 3-<9, 9-<18, 18-<27, 27+), oral contraceptive use 
(never, former, current), post-menopausal hormone use (premenopausal, never, former, current), race (Caucasian, other), family history of T2D (yes, no), 
incident high blood pressure (yes, no), incident high blood cholesterol  (yes, no), Alcohol intake (servings/d), multivitamin use (yes, no), total calories (per day: 
quintiles), whole milk (categorical: servings/d), bacon (categorical: servings/d), red meat (categorical: servings/d), other processed meat (categorical: servings/d), 
poultry (categorical: servings/d), fish (categorical: servings/d), refined carbohydrates (categorical: servings/d), potatoes (categorical: servings/d), coffee 
(categorical: servings/d), juice (categorical: servings/d), sugar-sweetened beverages (categorical: servings/d) 
†
P-values for trend based on continuous egg variable derived from the median egg intake in each category of consumption 
 
 
  Frequency of Egg Consumption 
p-
trend
†
 
HR (95% CI) for a 1 
serving per day 
increase 
BMI 
 ≤3/month 1/week 2-4/week ≥5/week 
<25 kg/m
2 
Cases/ Person years, No 614/832,900 776/764,294 417/420,149 89/83,198   
 HR (95% CI) 1 1.09 (0.98, 1.22) 1.16 (1.02, 1.31) 1.22 (0.97, 1.53) 0.87 1.02 (0.79, 1.32) 
25-<30 kg/m
2 
Cases/ Person years, No 1,349/451,497 2,020/519,969 1,067/284,949 208/55,908   
 HR (95% CI) 3.13 (2.84, 3.44) 3.42 (3.12, 3.75) 3.62 (3.27, 4.01) 3.51 (2.98, 4.13) 0.47 1.06 (0.90, 1.24) 
≥30 kg/m
2
 Cases/ Person years, No 2,555/234,018 3,702/285,830 1,995/154,154 417/28,921   
 HR (95% CI) 10.61 (9.70, 11.62) 10.25 (9.39, 11.20) 10.88 (9.90, 11.97) 11.30 (9.91, 12.89) 0.002 1.20 (1.07, 1.35) 
!∀#!
Results were attenuated when we examined eggs from all sources including mixed dishes (HR for 
≥2 egg/day: 1.05, 95% CI: (0.84, 1.30)) (Table 20). When we examined the risk of T2D according to egg 
intake additionally adjusted for dietary cholesterol, we found that results were attenuated, and no longer 
significant (HR for an increase of 1 egg/day: 1.02, 95% CI: (0.93, 1.13)) (Table 21).We also examined 
dietary cholesterol separately from egg intake. Dietary cholesterol was updated using the cumulative 
average method. We found a significantly increased risk of T2D across Q2 to Q5 of dietary cholesterol 
(HR(95% CI) by category: Q1 (Ref); Q2: 1.16(1.09, 1.22); Q3: 1.19(1.12, 1.25); Q4: 1.23(1.26, 1.30); 
Q5: 1.33(1.25, 1.42)) (Table 22).  When we examined the risk of T2D across quintiles of dietary 
cholesterol adjusting for egg intake, we saw a slight attenuation of risk across Q1-Q5 (HR(95% CI) by 
category: Q1 (Ref); Q2: 1.15(1.08, 1.22); Q3: 1.17(1.09, 1.24); Q4: 1.20(1.11, 1.28); Q5: 1.26(1.16, 
1.37)) (Table 23). When we further adjusted for red and processed meats in the model, we saw a larger 
attenuation of results, suggesting contribution of red and processed meats to the increased risk of T2D 
associated with dietary cholesterol (HR(95% CI) by category: Q1 (Ref); Q2: 1.12(1.05, 1.19); Q3: 
1.12(1.05, 1.20); Q4: 1.13(1.05, 1.22); Q5: 1.17(1.08, 1.28)). 
We did not find any clinically meaningful changes in egg intake after diagnosis with high blood 
pressure, high blood cholesterol or beginning statin use. When we stopped updating dietary information 
after diagnosis with one of these possible intermediate outcomes, we did not find any changes in risk of 
T2D (HR for 1 egg/day: 1.09, 95% CI: (0.97, 1.23)). Using a simple update of diet rather than cumulative 
average did not significantly change results (HR for 1 egg/day: 1.09, 95% CI: (0.98, 1.21)); however, 
using baseline diet only slightly attenuated the results, likely due to the long follow-up period between 
baseline diet and development of T2D (HR for 1 egg/day: 1.04, 95% CI: (0.95, 1.14)).  
 
 
 
 
!∀#!
Table 20. Risk of Incident Type 2 Diabetes According to Categories of Total Egg Consumption, Including Eggs in Mixed Foods
*
 
 Frequency of Consumption Categories  
p- 
trend
† 
HR (95% CI) 
for a 1 serving 
per day 
increase 
 <1/month 1-3/month 1/week 2-4/week 5-6/week 1/day ≥2/day 
Cases/Person-
years, No. 
808/300,339 2,481/848,173 7,493/1,997,155 4,653/1,158,450 568/122,440 469/108,537 98/24,496   
NHS 1 0.92 (0.79, 1.06) 0.89 (0.77, 1.02) 0.95 (0.82, 1.09) 1.05 (0.88, 1.25) 0.95 (0.78, 1.15) 1.13 (0.80, 1.61) 0.04 1.11 (1.01, 1.22) 
NHSII 1 0.93 (0.82, 1.05) 0.92 (0.82, 1.04) 1.00 (0.88, 1.14) 1.09 (0.85, 1.39) 0.99 (0.72, 1.36) 0.52 (0.16, 1.65) 0.25 1.10 (0.94, 1.28) 
HPFS 1 1.11 (0.94, 1.30) 1.11 (0.95, 1.29) 1.09 (0.93, 1.28) 1.04 (0.83, 1.29) 1.14 (0.93, 1.40) 1.15 (0.85, 1.56) 0.64 1.02 (0.93, 1.13) 
Pooled Results 1 0.97 (0.90, 1.05) 0.96 (0.89, 1.03) 1.01 (0.93, 1.09) 1.06 (0.94, 1.18) 1.01 (0.89, 1.14) 1.05 (0.84, 1.30) 0.06 1.06 (1.00, 1.13) 
*
All results are from Multivariable Model 3 and include: age (months), sex (male, female), smoking status (never, former, current), BMI (kg/m
2
: categorical <21, 
21-<23, 23-<25, 25-<27, 27-<30, 30-<35, 35-<40, 40+), physical activity (MET-hours/week: categorical <3, 3-<9, 9-<18, 18-<27, 27+), oral contraceptive use 
(never, former, current), post-menopausal hormone use (premenopausal, never, former, current), race (Caucasian, other), family history of T2D (yes, no), 
incident high blood pressure (yes, no), incident high blood cholesterol  (yes, no), Alcohol intake (servings/d), multivitamin use (yes, no), total calories (per day: 
quintiles), whole milk (categorical: servings/d), bacon (categorical: servings/d), red meat (categorical: servings/d), other processed meat (categorical: servings/d), 
poultry (categorical: servings/d), fish (categorical: servings/d), refined carbohydrates (categorical: servings/d), potatoes (categorical: servings/d), coffee 
(categorical: servings/d), juice (categorical: servings/d), sugar-sweetened beverages (categorical: servings/d) 
†
P-values for trend based on continuous egg variable derived from the median egg intake in each category of consumption 
 
Table 21. Risk of Incident Type 2 Diabetes According to Egg Intake, Adjusting for Dietary Cholesterol
*
 
 Frequency of Consumption Categories 
p- trend
† 
HR (95% CI) 
for a 1 egg per 
day increase 
Cohort <1/month 1-3/month 1/week 2-4/week 5-6/week ≥1/day 
Pooled 1 1.01 (0.94, 1.07) 0.99 (0.92, 1.05) 1.04 (0.96, 1.12) 1.13 (1.00, 1.28) 0.99 (0.87, 1.12) 0.64 1.02 (0.93, 1.13) 
*
All results are from Multivariable Model 3 and include: dietary cholesterol (quintiles: mg/d), age (months), sex (male, female), smoking status (never, former, 
current), BMI (kg/m
2
: categorical <21, 21-<23, 23-<25, 25-<27, 27-<30, 30-<35, 35-<40, 40+), physical activity (MET-hours/week: categorical <3, 3-<9, 9-<18, 
18-<27, 27+), oral contraceptive use (never, former, current), post-menopausal hormone use (premenopausal, never, former, current), race (Caucasian, other), 
family history of T2D (yes, no), incident high blood pressure (yes, no), incident high blood cholesterol  (yes, no), Alcohol intake (servings/d), multivitamin use 
(yes, no), total calories (per day: quintiles), whole milk (categorical: servings/d), bacon (categorical: servings/d), red meat (categorical: servings/d), other 
processed meat (categorical: servings/d), poultry (categorical: servings/d), fish (categorical: servings/d), refined carbohydrates (categorical: servings/d), potatoes 
(categorical: servings/d), coffee (categorical: servings/d), juice (categorical: servings/d), sugar-sweetened beverages (categorical: servings/d) 
†
P-values for trend based on continuous egg variable derived from the median egg intake in each category of consumption 
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Table 22. Risk of Incident Type 2 Diabetes According to Quintiles of Dietary Cholesterol
*
 
 Quintiles of Dietary Cholesterol 
p- trend
†
 
HR (95% CI) for a 
200mg per day 
increase 
 Q1 Q2 Q3 Q4 Q5 
Median (mg/d) 155.0 215.0 262.6 311.0 398.2   
Pooled 1 1.16 (1.09, 1.22) 1.19 (1.12, 1.25) 1.23 (1.26, 1.30) 1.33 (1.25, 1.42) <0.001 1.14 (1.10, 1.18) 
*
All results are from Multivariable Model 3 and include: age (months), sex (male, female), smoking status (never, former, current), BMI (kg/m
2
: categorical <21, 
21-<23, 23-<25, 25-<27, 27-<30, 30-<35, 35-<40, 40+), physical activity (MET-hours/week: categorical <3, 3-<9, 9-<18, 18-<27, 27+), oral contraceptive use 
(never, former, current), post-menopausal hormone use (premenopausal, never, former, current), race (Caucasian, other), family history of T2D (yes, no), 
incident high blood pressure (yes, no), incident high blood cholesterol (yes, no), Alcohol intake (servings/d), multivitamin use (yes, no), total calories (per day: 
quintiles), whole milk (categorical: servings/d), refined carbohydrates (categorical: servings/d), potatoes (categorical: servings/d), coffee (categorical: 
servings/d), juice (categorical: servings/d), sugar-sweetened beverages (categorical: servings/d) 
†
P-values for trend based on continuous dietary cholesterol derived from the median in each quintile 
 
Table 23. Risk of Incident Type 2 Diabetes According to Dietary Cholesterol from Sources Other than Egg Intake
*
 
 Quintiles of Dietary Cholesterol 
p- trend
†
 
HR (95% CI) for a 
200mg per day 
increase 
 Q1 Q2 Q3 Q4 Q5 
Median (mg/d) 155.0 215.0 262.6 311.0 398.2   
Pooled 1 1.15 (1.08, 1.22) 1.17 (1.09, 1.24) 1.20 (1.11, 1.28) 1.26 (1.16, 1.37) <0.001 1.13 (1.07, 1.19) 
*
All results are from Multivariable Model 3 and include: egg intake (categorical <1/month, 1-3/month, 1/week, 2-4/week, 5-6/week, ≥1/day), age (months), sex 
(male, female), smoking status (never, former, current), BMI (kg/m
2
: categorical <21, 21-<23, 23-<25, 25-<27, 27-<30, 30-<35, 35-<40, 40+), physical activity 
(MET-hours/week: categorical <3, 3-<9, 9-<18, 18-<27, 27+), oral contraceptive use (never, former, current), post-menopausal hormone use (premenopausal, 
never, former, current), race (Caucasian, other), family history of T2D (yes, no), incident high blood pressure (yes, no), incident high blood cholesterol  (yes, no), 
Alcohol intake (servings/d), multivitamin use (yes, no), total calories (per day: quintiles), whole milk (categorical: servings/d), refined carbohydrates 
(categorical: servings/d), potatoes (categorical: servings/d), coffee (categorical: servings/d), juice (categorical: servings/d), sugar-sweetened beverages 
(categorical: servings/d) 
†
P-values for trend based on continuous egg variable derived from the median egg intake in each category of consumption 
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In our meta-analysis of egg intake and risk of T2D, we identified 583 articles from the literature 
search. 582 articles were found by searching PubMed and Embase and one additional article was found 
though a review of the article references. We excluded 567 articles that did not mention both eggs and 
T2D, leaving 16 articles for full text review (Figure 8). Of these, 10 were excluded. Three were review 
articles, 2 were commentaries, 2 did not have T2D as the outcome, 2 were not prospective cohorts and 1 
had egg intake less than 1 egg per week. A total of 7 studies were included in the meta-analyses, 
including the current analyses (Table 24). With fixed effects meta-analysis, we observed an increased risk 
of T2D with an increase of one egg per day (HR: 1.13, 95% CI: (1.07, 1.19)) (Figure 9A). When random 
effects meta-analysis was used, more weight was given to smaller studies and the results were attenuated 
and no longer significant (HR: 1.04, 95% CI: (0.88, 1.23)) (Figure 9B). 
 
!
 
Figure 8. Meta-analysis Search Strategy and Study Selection 
583 articles identified from search 
 582 articles from PubMed/EMBASE using search terms 
 1 article from review of references 
567 articles excluded that did not mention both 
egg intake and type 2 diabetes 
16 full text articles reviewed 
10 articles excluded 
 3 review articles 
 2 commentaries 
 2 articles without T2D as the outcome 
 1 case control design 
 1 cross sectional design 
 1 where egg intake was 1/week or less 
7 articles included in meta-analysis 
 6 prospective cohorts 
 and the current study 
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Table 24. Meta-analysis Study Characteristics 
Study Study Population Country 
Number of 
Participants 
Age Range 
Study Type 
(Follow-up) 
Assessment of 
Exposure 
Categories of 
Exposure 
Number of 
Cases 
Djousse et 
al. 2009 
Physicians' Health 
Study (PHS); 
Womens' Health 
Study (WHS) 
USA 20,703 Men; 
36,295 Women 
Men: 39.7-
85.9 y; 
Women: 
38.7-89.9 y 
Prospective 
Cohort (Men: 
10.0 y mean; 
Women: 11.7 
y mean) 
Semi-
quantitative 
FFQ 
0; <1/wk; 
1/wk; 2-4/wk; 
5-6/wk; ≥7/wk 
1,921 Men; 
2,112 
Women 
Djousse et 
al. 2010 
Cardiovascular 
Health Study 
(CHS) 
USA 3,898 Men and 
Women 
≥65 y Prospective 
Cohort (11.3 y 
mean) 
Semi-
quantitative 
FFQ 
Never; <1/mo; 
1-3/mo; 1-
4/wk; Almost 
daily 
142 Men; 
171 
Women 
Djousse et 
al. 2015 
Jackson Heart 
Study 
USA 3,564 African 
American Men 
21-95 y Prospective 
Cohort (7.3 y 
mean) 
Semi- 
quantitative 
FFQ 
<1/mo; 1-
3/mo; 1/wk; 
2/wk; 3-4/wk; 
≥5/wk 
531 Men 
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Table 24 (Continued) 
Study Study Population 
Ascertainment of 
Cases 
Statistical 
Model 
Relative Risks (95% CI) 
Covariates in Multivariate 
Model 
Djousse et al. 
2009 
Physicians' Health 
Study (PHS); 
Womens' Health 
Study (WHS) 
Self-report validated 
through telephone 
interviews, 
supplemental 
questionnaires or 
review of medical 
records 
Cox proportional 
hazards 
Men: 0: 1(Ref); <1/wk: 1.09 
(0.87, 1.37); 1/wk: 1.09(0.88, 
1.34); 2-4/wk: 1.18(0.95, 
1.45); 5-6/wk: 1.46(1.14, 
1.86); ≥7/wk: 1.58(1.25, 2.01); 
Women:  0: 1(Ref); <1/wk: 
1.06(0.92, 1.22); 1/wk: 
0.97(0.83, 1.12); 2-4/wk: 
1.19(1.03, 1.38); 5-6/wk: 
1.18(0.88, 1.58); ≥7/wk: 
1.77(1.28, 2.43) 
Men: age, BMI, smoking, alcohol, 
exercise ,history of 
hypercholesterolemia and 
hypertension,                                       
Women: age, BMI, smoking, 
alcohol, exercise, red meat, 
energy intake, fruits, vegetables, 
saturated fatty acids, trans fatty 
acids, family history of diabetes, 
history of hypercholesterolemia 
and hypertension 
Djousse et al. 
2010 
Cardiovascular 
Health Study (CHS) 
Report of new use of 
insulin or oral 
hypoglycemia agents, 
fasting plasma 
glucose  >7.0 
mmol/L, or non-
fasting plasma 
glucose >11.1 
mmol/L 
Cox proportional 
hazards 
Men: Never: 1(Ref); <1/mo: 
0.95(0.45, 2.01); 1-3/mo: 
1.14(0.60, 2.5); 1-4/wk: 
0.96(0.50, 1.82); Almost daily: 
1.81(0.77, 4.22);                             
Women: Never: 1(Ref); 
<1/mo: 0.77(0.43, 1.38); 1-
3/mo: 0.73(0.47, 1.14); 1-4/wk: 
0.76(0.47, 1.23); Almost daily: 
0.38(0.10, 1.37) 
age, race, BMI, smoking, alcohol, 
physical activity, cereal-fiber 
intake, field center 
Djousse et al. 
2015 
Jackson Heart Study Fasting glucose ≥126 
mg/dL, A1c ≥6.5% or 
use of insulin or oral 
hypoglycemic 
medication  
Cox proportional 
hazards 
<1/mo(Ref); 1-3/mo: 
0.88(0.65, 1.19); 1/wk: 
0.94(0.68, 1.30); 2/wk: 
0.91(0.66, 1.25); 3-4/wk: 
1.11(0.81, 1.52); ≥5/wk: 
1.17(0.81, 1.70) 
Age, sex, smoking, alcohol, BMI, 
physical activity score, education, 
energy intake, red meat and 
bacon, fiber, dietary magnesium, 
fruit/vegetables, trans fat, waist 
circumference, history of 
hypertension and history of CVD 
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Table 24 (Continued) 
Study Study Population Country 
Number of 
Participants 
Age Range 
Study Type 
(Follow-up) 
Assessment of 
Exposure 
Categories of 
Exposure 
Number of 
Cases 
Kurotani et al. 
2014 
Japan Public Health 
Center-based 
Prospective Study 
Japan 27,248 Men and 
36,218 Women 
40-69 y Prospective 
Cohort (5 y) 
Semi-
quantitative FFQ 
Quartiles: Men: 
7.7g/d; 19.4g/d; 
32.6g/d; 
55.0g/d;  
Women: 
6.9g/d; 17.5g/d; 
29.4g/d; 
50.3g/d 
672 Men; 
493 Women 
Virtanen et al. 
2015 
Kuopio Ischaemic 
Heart Disease Risk 
Factor Study 
Finland 2,332 Men 42-60 y Prospective 
Cohort  (19.3 y) 
Guided 4-day 
food record 
Quartiles: 
<14g/d; 14-
26g/d; 27-
45g/d; >45g/d 
432 
Zazpe et al. 
2013 
The Sun project Spain 15,956 men and 
women 
20-90 y Prospective 
Cohort (6.6 y 
mean) 
Semi-
quantitative FFQ 
<1/week; 
1/week; 2-
4/week; 
>4/week 
91 
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Table 24 (Continued) 
Study Study Population 
Ascertainment of 
Cases 
Statistical Model Relative Risks (95% CI) Covariates in Multivariate Model 
Kurotani et al. 
2014 
Japan Public Health 
Center-based 
Prospective Study 
Self-report disease 
history questionnaire 
Multivariate 
logistic regression 
Men: Q1(Ref); Q2: 0.93(0.74, 
1.15); Q3: 0.93 (0.74, 1.16); Q4: 
1.06 (0.85, 1.32); 
Women: Q1(Ref); 
Q2:1.01(0.79, 1.29); Q3: 
0.94(0.73, 1.21); Q4: 0.82(0.63, 
1.06) 
Age, public health center area, 
BMI, smoking status, alcohol 
consumption, total physical activity 
levels, history of hypertension, 
family history of diabetes, Mg 
intake, Ca intake, coffee, rice, fish, 
shellfish, meat, vegetables, soft 
drinks and total energy 
Virtanen et al. 
2015 
Kuopio Ischaemic 
Heart Disease Risk 
Factor Study 
Self-reported, fasting 
plasma glucose ≥7.0 
mmol/L or 2-hr OGTT 
plasma glucose ≥11.1 
mmol/L 
Cox proportional 
hazards 
<14g/d: 1(Ref); 14-26g/d: 
0.90(0.69, 1.16); 27-45g/d: 
0.59(0.44, 0.80); >45g/d: 
0.55(0.38, 0.79) 
Age, examination year, energy 
intake, BMI, family history of type 
2 diabetes, hypertension, smoking, 
education years, leisure-time 
physical activity, serum long-chain 
omega-3 PUFAs, alcohol, linoleic 
acid, fiber, fruit, berries, vegetables 
Zazpe et al. 2013 The Sun project Self-report validated 
through supplemental 
questionnaires and 
medical record review 
Multivariate 
logistic regression 
<1/week: 1(Ref); 1/week: 0.9 
(0.4, 1.8); 2-4/week: 0.6 (0.3, 
1.2); >4/week: 0.7 (0.3, 1.7) 
Age, sex, total energy intake, 
adherence to Mediterranean food 
pattern, alcohol, baseline BMI, 
smoking status, leisure time 
physical activity, family history of 
T2D, self-reported hypertension, 
hypercholesterolemia and  
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Figure 9. Risk of Type 2 Diabetes Associated with an Increase in Consumption of 1 egg/day using fixed (A) and 
random (B) effects meta-analysis. Weights of each of the studies are represented by the size of the square. Black 
diamonds represent the individual study effects and black lines represent the 95% confidence intervals. The overall 
effect estimate and 95% confidence interval is represented by the diamond and dotted line. Abbreviations: Nurses’ 
Health Study (NHS), Nurses’ Health Study II (NHSII), Health Professionals Follow-up Study (HPFS). 
 
NOTE: Weights are from random effects analysis
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DISCUSSION 
After adjustment for dietary and lifestyle factors we observed a modest association between 
higher egg intake and risk of T2D. In the meta-analysis of 9 cohorts, we found a similar association 
between egg intake of one egg per day and risk of T2D that was significant for the fixed effects meta-
analysis, but not for random effects.  We observed a significantly decreased risk of T2D when 
substituting eggs for legumes, low-fat dairy, nuts and whole grains, and a significantly increased risk of 
T2D when substituting eggs for red and processed meats. These results suggest that healthy alternatives to 
egg consumption include legumes, low-fat dairy, nuts and whole grains. 
Findings from previously published cohort studies have been inconsistent, likely due to the 
differences in adjustment for confounders and follow-up time. The Japan Public Health Center-based 
prospective study, the Sun Project, the Jackson Heart Study and the Kuopio Ischaemic Heart Disease Risk 
Factor Study did not find an increased risk of T2D associated with egg intake after adjustment for 
potential confounders including dietary variables 
19-21, 60
. While the Physician’s Health Study, Women’s 
Health Study and men in the Cardiovascular Health Study reported a significantly increased risk of T2D 
with higher egg consumption, it is possible that the associations seen in the Physician’s Health and 
Cardiovascular Health Studies would have been attenuated if authors had been able to adjust for 
additional confounders such as diet, family history of T2D, and history of hypertension and high blood 
cholesterol 
16, 59
. Recently, the upper limit for dietary cholesterol was not carried forward in the 2015 
Dietary Guidelines Advisory Committee Report due to the lack of an appreciable relationship between 
dietary and blood cholesterol 
3
. Although eggs are a major source of dietary cholesterol, containing about 
200mg, they also provide a variety of other nutrients beneficial to health such as unsaturated fats, amino 
acids, and B-vitamins, potentially offsetting any harmful effects of dietary cholesterol 
4
. In our cohorts, 
there was a slight positive association between dietary cholesterol and T2D, but there was no dose 
response relationship. In addition, adjustment for dietary cholesterol further attenuated the association 
between egg consumption and T2D, suggesting that the effect of egg intake is mediated by dietary 
cholesterol. 
!∀∀!
 
We observed a consistent association between egg consumption and T2D across subgroups in 
several stratified analyses by diabetes risk factors. However, we also observed significant interactions for 
hypertension, high blood cholesterol and statin use, which we cannot explain. Of note, we observed no 
significant changes in egg intake after diagnosis of hypertension, high blood cholesterol or beginning 
statin use; however, overall egg intake was lower in these participants. No previous publications have 
reported similar interactions; therefore, these results should be interpreted with caution and require further 
confirmation.  
It is possible that the increased risk of T2D seen among participants with normal blood 
cholesterol is due to some additional unmeasured confounding among less healthy participants, obscuring 
the relationship between egg consumption and T2D seen among the healthy population. Indeed, the risk 
of T2D for an increase of 1 egg per day is attenuated in participants who report a higher number of 
unhealthy lifestyle factors such as low physical activity, BMI>25, family history of type 2 diabetes, 
hypertension, high blood cholesterol, angina, CABG and smoking.  
We observed a large amount of heterogeneity in our meta-analysis. There was no one study that 
contributed a significant amount of heterogeneity, and stratification by number of cases, total number of 
participants, sex, country, length of follow-up and whether there were repeated measures of diet during 
follow-up could not explain the differences among studies. Although we see a significantly increased risk 
of T2D with egg intake in the fixed effects meta-analysis, the relationship is attenuated when random 
effects is used. Therefore, results from the meta-analysis should be interpreted cautiously.  
These analyses provide several strengths including the large sample size, detailed and updated 
information on diet and lifestyle, and high rates of follow-up. Previously published cohort studies have 
lacked sufficient follow-up time or adjustment for dietary confounders. In the current analyses we were 
able to adjust for dietary factors related to egg intake such as bacon, red and processed meat, coffee, juice, 
sugar sweetened beverages, whole milk and refined carbohydrates. In addition, our analysis includes 
16,867 cases, while the largest previous study, the Women’s Health Study includes only 2,112 cases 
59
. 
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The collection of updated dietary information and use of cumulative average update allows us to account 
for differences in intake within people and limit random measurement error, while allowing for changes 
over time. Thus, these analyses also offer the ability to strengthen the meta-analysis of current literature.  
There are limitations of the current analyses. There is a possibility of misclassification of dietary 
variables due to random measurement error possible with the FFQ. If present, this type of error would 
cause an underestimation of the association between egg intake and T2D. Dietary intake measured via the 
FFQ has been validated against weighed 7-day records and shows high de-attenuated correlations for egg 
intake (NHS=0.77, HPFS=0.80) 
31
. In addition, the method for updating dietary information, cumulative 
average update, minimizes some of the possible measurement error due to the FFQ. Although our sample 
is less generalizable to other populations due to the participants being predominantly of European 
ancestry, the high education level in this population has likely enhanced the quality of the data collected. 
Due to the observational nature of this study we cannot infer causation and cannot eliminate the 
possibility that some unmeasured or residual confounding remains; however, this is limited by adjustment 
for a number of possible confounders including dietary and lifestyle factors. 
Higher egg intake is associated with a small increased risk of T2D in the prospective cohort 
studies NHS, NHSII and HPFS. These results were quantitatively similar to a meta-analysis of the current 
literature, which also found a significant association with egg intake and risk of T2D using random 
effects, but not with fixed effects. In addition, our analyses suggest that healthy alternatives to egg intake 
include legumes, low-fat dairy, nuts and whole grains. 
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CONCLUSION 
 
The prevention of chronic diseases such as T2D and CVD are of high importance. Many foods 
are associated with increased or decreased risks of these diseases, and it is important to understand these 
relationships to make food-based dietary recommendations. Specifically, for egg intake, the debate has 
lasted decades from the original proposal of the diet-heart hypothesis. 
In chapter 1, we did not observe any association between egg intake and the risk of CVD in 
NHSI, NHSII or HPFS. However, we observed an increased risk of CVD among participants with T2D. 
We also found that replacing eggs with one serving of low fat dairy, whole grains or nuts resulted in a 
decreased risk of CVD, while replacing eggs with red and processed meats resulted in an increased risk of 
CVD. 
In chapter 2, we observed a small positive association between egg intake and the risk of CVD 
mortality in the AARP study. It is possible that this increase may be driven by participants with T2D, 
evidenced by the increased risk of CVD mortality with egg intake seen among participants reporting T2D 
at baseline. When we combined previously published cohorts using meta-analysis we saw a slight positive 
association between increases of one egg per day and risk of CVD. This association was no longer present 
when we used a random-effects meta-analysis and may be due to unmeasured confounding in many of the 
studies.  
In chapter 3, we found an increased risk of T2D with an increase in intake of one egg per day in 
the NHS, NHSII and HPFS cohorts. Replacement of eggs for legumes, low fat dairy, nuts and whole 
grains all resulted in a decreased risk of T2D, while replacement of eggs with red and processed meats 
resulted in an increased risk. These findings were quantitatively similar to our meta-analysis; however, 
results were not statistically significant using random effects. These meta-analysis results should be 
interpreted with caution due to the large amount of heterogeneity between the studies included.  
In summary, it appears that there is no association between egg intake and risk of CVD among 
healthy individuals. However, individuals at higher risk for CVD, such as those with T2D, may consider 
reducing egg intake. In addition, there is a slight increased risk of T2D with increases in egg intake of one 
!%∋!
egg per day. Further research is needed to confirm findings among people at higher risk for CVD and 
T2D. Although eggs can be included as part of a healthy diet in individuals at low risk for CVD and T2D, 
there are many healthy alternatives to egg intake, which include low fat dairy, whole grains, legumes and 
nuts.  
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